{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:17:22Z","timestamp":1794532642696,"version":"4.9.1"},"reference-count":1108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.molmet.2025.102118","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:42:52Z","timestamp":1740742972000},"page":"102118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Glucose-dependent insulinotropic polypeptide (GIP)"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-9339","authenticated-orcid":false,"given":"Timo D.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Adriaenssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ahr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D'Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn F.","family":"Deacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"DelPrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Douros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Figueredo Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E.","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Gribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Knerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip K.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Kusminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Liskiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Mabilleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Mowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Novikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Samms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy J.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle W.","family":"Sloop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wolfrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Wootten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"DiMarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias H.","family":"Tsch\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2025.102118_bib1","series-title":"Die Arbeit der Verdauungsdr\u00fcsen","author":"Pawlow","year":"1898"},{"key":"10.1016\/j.molmet.2025.102118_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01667331","article-title":"Ueber das peripherische r\u0113ectorische Nervenzentrum des Pankreas","volume":"86","author":"Popielski","year":"1901","journal-title":"Pfl\u00fcgers Arch Ges Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib3","article-title":"Secretion pancreatique et atropine","volume":"759","author":"Wertheimer","year":"1901","journal-title":"Comp rend Soc de biol"},{"key":"10.1016\/j.molmet.2025.102118_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/jphysiol.1902.sp000920","article-title":"The mechanism of pancreatic secretion","volume":"28","author":"Bayliss","year":"1902","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1113\/jphysiol.1906.sp001146","article-title":"The chemical mechanism of gastric secretion","volume":"34","author":"Edkins","year":"1906","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib6","first-page":"376","article-title":"On the chemical mechanism of gastric secretion (Abstract)","volume":"76","author":"Edkins","year":"1905","journal-title":"Proc Roy Soc Lond"},{"key":"10.1016\/j.molmet.2025.102118_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/ajplegacy.1928.86.3.599","article-title":"A\u00a0hormone mechanism for gallbladder contraction and evacuation","volume":"86","author":"Ivy","year":"1928","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9258(18)87274-X","article-title":"The action of intravenous injections of pancreas emulsions in experimental diabetes","volume":"40","author":"Kleiner","year":"1919","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib9","first-page":"85","article-title":"Recherche sur le r\u00f4le du pancr\u00e9as dans l'assimilation nutritive","volume":"17","author":"Paulescu","year":"1921","journal-title":"Arch Int Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib10","first-page":"391","article-title":"Delayed manifestation of the physiological effects of insulin following the administration of certain pancreatic extracts","volume":"63","author":"Collip","year":"1923","journal-title":"Am J Phys"},{"key":"10.1016\/j.molmet.2025.102118_bib11","first-page":"57","article-title":"Preparation of insulin","volume":"67","author":"Fisher","year":"1923","journal-title":"Am J Phys"},{"key":"10.1016\/j.molmet.2025.102118_bib12","first-page":"141","article-title":"Pancreatic extracts in the treatment of diabetes mellitus","volume":"12","author":"Banting","year":"1922","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.molmet.2025.102118_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0021-9258(18)85474-6","article-title":"Aqueous extracts of pancreas III. Some precipitation reactions of insulin","volume":"58","author":"Kimball","year":"1923","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib14","series-title":"The mechanical factors of digestion","author":"Cannon","year":"1911"},{"key":"10.1016\/j.molmet.2025.102118_bib15","series-title":"Experiments and observations on the gastric juice and the physiology of digestion","author":"Beaumont","year":"1833"},{"key":"10.1016\/j.molmet.2025.102118_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1152\/ajplegacy.1934.108.3.643","article-title":"Analysis of the factors involved in gastric motor inhibition by fats","volume":"108","author":"Quigley","year":"1934","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib17","series-title":"The work of the digestive glands","article-title":"The work of the digestive glands","author":"Pavlow","year":"1910"},{"key":"10.1016\/j.molmet.2025.102118_bib18","article-title":"On the mechanisms of the inhibition of gastric secretion by fat","volume":"3","author":"Feng","year":"1929","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3181\/00379727-27-5024","article-title":"Demonstration of the humoral agent in fat inhibition of gastric secretion","volume":"27","author":"Kosaka","year":"1930","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.molmet.2025.102118_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/00365521.1970.12096632","article-title":"A\u00a0multiparameter study on the action of preparations containing cholecystokinin-pancreozymin","volume":"5","author":"Brown","year":"1970","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib21","series-title":"The isolation and physiological actions of GIP","author":"Pederson","year":"1971"},{"key":"10.1016\/j.molmet.2025.102118_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1432-1033.1970.tb01034.x","article-title":"Structure of porcine secretin. The amino acid sequence","volume":"15","author":"Mutt","year":"1970","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1432-1033.1968.tb00433.x","article-title":"Structure of porcine cholecystokinine. I. Cleavage with thrombin and trypsin","volume":"6","author":"Mutt","year":"1968","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1113\/jphysiol.1970.sp009155","article-title":"Further purification of a polypeptide demonstrating enterogastrone activity","volume":"209","author":"Brown","year":"1970","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1139\/y69-020","article-title":"Preparation of highly active enterogastrone","volume":"47","author":"Brown","year":"1969","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib26","first-page":"487","article-title":"Identification and actions of gastric inhibitory polypeptide","volume":"31","author":"Brown","year":"1975","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.molmet.2025.102118_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1042\/bj0010028","article-title":"On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane","volume":"1","author":"Moore","year":"1906","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib28","first-page":"20","article-title":"Contributiona a l'etude des variations physiologiques de la secretion interne du pancreas: Relations entre les secretions externe et interne du pancreas","volume":"31","author":"Zunz","year":"1929","journal-title":"Arch Int Physiol Biochim"},{"key":"10.1016\/j.molmet.2025.102118_bib29","first-page":"620","article-title":"Sur les possibilite's d'un traitement du diab\u00e8te par l'incr\u00e9tine","volume":"12","author":"La Barre","year":"1932","journal-title":"Bull Acad R Med Belg"},{"key":"10.1016\/j.molmet.2025.102118_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/ajplegacy.1940.129.3.659","article-title":"Is a duodenal hormone involved in carbohydrate metabolism?","volume":"129","author":"Loew","year":"1940","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1152\/ajplegacy.1939.126.2.270","article-title":"The effect of duodenal instillation of hydrochloric acid upon the fasting blood sugar of dogs","volume":"126","author":"Loew","year":"1939","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/ajplegacy.1939.128.2.298","article-title":"The effect of acid stimulation of the duodenum upon experimental hyperglycemia and utilization of glucose","volume":"128","author":"Loew","year":"1940","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.regpep.2004.08.004","article-title":"The [pre-] history of the incretin concept","volume":"128","author":"Creutzfeldt","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1152\/physrev.1950.30.1.33","article-title":"Gastrointestinal hormones","volume":"30","author":"Grossman","year":"1950","journal-title":"Physiol Rev"},{"key":"10.1016\/j.molmet.2025.102118_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archinte.1969.00300130043007","article-title":"Entero-insular axis","volume":"123","author":"Unger","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.molmet.2025.102118_bib36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1172\/JCI105565","article-title":"The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs","volume":"46","author":"Unger","year":"1967","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1152\/ajplegacy.1954.179.3.435","article-title":"Quantitative relations between the oral and intravenous glucose tolerance curves","volume":"179","author":"Scow","year":"1954","journal-title":"Am J Physiol"},{"issue":"Suppl 21","key":"10.1016\/j.molmet.2025.102118_bib38","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/1841648b0","article-title":"Assay of plasma insulin in human subjects by immunological methods","volume":"184","author":"Yalow","year":"1959","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib39","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1172\/JCI104130","article-title":"Immunoassay of endogenous plasma insulin in man","volume":"39","author":"Yalow","year":"1960","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib40","first-page":"1122","article-title":"Insulin response and glucose-C14 disappearance rate during the glucose tolerance test in the unanesthetized dog","volume":"12","author":"Arnould","year":"1963","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib41","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jcem-24-10-1076","article-title":"Plasma insulin response to oral and intravenous glucose administration","volume":"24","author":"Elrick","year":"1964","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(64)90011-X","article-title":"New interpretation of oral glucose tolerance","volume":"2","author":"McIntyre","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(64)92481-X","article-title":"An intestinal hormone affecting glucose disposal in man","volume":"2","author":"Dupre","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2337\/diab.15.8.555","article-title":"Stimulation of release of insulin by an extract of intestinal mucosa","volume":"15","author":"Dupre","year":"1966","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib45","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1210\/jcem-37-5-826","article-title":"Stimulation of insulin secretion by gastric inhibitory polypeptide in man","volume":"37","author":"Dupre","year":"1973","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib46","first-page":"493","article-title":"Stimulation of (Pro-)insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas","volume":"91","author":"Schafer","year":"1979","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00429919","article-title":"Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in\u00a0vitro","volume":"11","author":"Schauder","year":"1975","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib48","first-page":"416","article-title":"Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in\u00a0vitro in the rat","volume":"99","author":"Szecowka","year":"1982","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2337\/diab.26.5.480","article-title":"Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat","volume":"26","author":"Taminato","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF01228136","article-title":"Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas","volume":"14","author":"Adrian","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0022-4804(90)90058-A","article-title":"Selective neurohormonal interactions in islet cell secretion in the isolated perfused human pancreas","volume":"48","author":"Brunicardi","year":"1990","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.molmet.2025.102118_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0168-8227(91)90059-M","article-title":"Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man","volume":"13","author":"Ahren","year":"1991","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.molmet.2025.102118_bib53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0300-5089(21)00478-8","article-title":"Gastric inhibitory polypeptide","volume":"9","author":"Ebert","year":"1980","journal-title":"Clin Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01308308","article-title":"Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man","volume":"25","author":"Maxwell","year":"1980","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365527809179804","article-title":"Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release","volume":"13","author":"Arnold","year":"1978","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib56","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/diabetes.54.4.1056","article-title":"Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility","volume":"54","author":"Miki","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib57","doi-asserted-by":"crossref","first-page":"E621","DOI":"10.1152\/ajpendo.00499.2003","article-title":"Gastric inhibitory polypeptide does not inhibit gastric emptying in humans","volume":"286","author":"Meier","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000200956","article-title":"Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects","volume":"52","author":"Nauck","year":"1992","journal-title":"Digestion"},{"key":"10.1016\/j.molmet.2025.102118_bib59","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1210\/endo-99-3-780","article-title":"The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas","volume":"99","author":"Pederson","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib60","first-page":"568","volume":"vol. 2","author":"Brown","year":"1977"},{"issue":"III-XI","key":"10.1016\/j.molmet.2025.102118_bib61","first-page":"1","article-title":"Gastric inhibitory polypeptide","volume":"24","author":"Brown","year":"1982","journal-title":"Monogr Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170276","article-title":"The early history of GIP 1969-2000: from enterogastrone to major metabolic hormone","volume":"125","author":"Marks","year":"2020","journal-title":"Peptides"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2025.102118_bib63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdi.12480","article-title":"Discovery of gastric inhibitory polypeptide and its subsequent fate: personal reflections","volume":"7","author":"Pederson","year":"2016","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/diab.9.5.356","article-title":"Comparison of plasma insulin levels following administration of tolbutamide and glucose","volume":"9","author":"Yalow","year":"1960","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(65)90761-0","article-title":"Promotion of insulin secretion by glucagon","volume":"2","author":"Samols","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/00365528009181538","article-title":"Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man","volume":"15","author":"Lauritsen","year":"1980","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00257346","article-title":"Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption","volume":"24","author":"Ebert","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib68","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.79.2.345","article-title":"Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem","volume":"79","author":"Lund","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib69","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1016\/S0021-9258(19)69015-0","article-title":"Pancreatic pre-proglucagons are encoded by two separate mRNAs","volume":"256","author":"Lund","year":"1981","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib70","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1016\/S0021-9258(18)32858-8","article-title":"Anglerfish islet pre-proglucagon II. Nucleotide and corresponding amino acid sequence of the cDNA","volume":"258","author":"Lund","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib71","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/302716a0","article-title":"Hamster preproglucagon contains the sequence of glucagon and two related peptides","volume":"302","author":"Bell","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib72","doi-asserted-by":"crossref","first-page":"14082","DOI":"10.1016\/S0021-9258(18)89859-3","article-title":"Glucagon gene sequence. Four of six exons encode separate functional domains of rat pre-proglucagon","volume":"259","author":"Heinrich","year":"1984","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib73","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1210\/endo-115-6-2176","article-title":"Pre-proglucagon messenger ribonucleic acid: nucleotide and encoded amino acid sequences of the rat pancreatic complementary deoxyribonucleic acid","volume":"115","author":"Heinrich","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib74","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/304368a0","article-title":"Exon duplication and divergence in the human preproglucagon gene","volume":"304","author":"Bell","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib75","doi-asserted-by":"crossref","first-page":"11880","DOI":"10.1016\/S0021-9258(18)67324-7","article-title":"Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing","volume":"261","author":"Mojsov","year":"1986","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(87)81430-8","article-title":"Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut","volume":"211","author":"Holst","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.molmet.2025.102118_bib77","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI112855","article-title":"Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas","volume":"79","author":"Mojsov","year":"1987","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib78","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1073\/pnas.84.10.3434","article-title":"Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line","volume":"84","author":"Drucker","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib79","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib80","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.14.4.284","article-title":"Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum","volume":"14","author":"Polak","year":"1973","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.molmet.2025.102118_bib81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gut.15.6.502","article-title":"Progress report. Radioimmunoassay of intestinal hormones","volume":"15","author":"Bloom","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2025.102118_bib82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00492251","article-title":"Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man","volume":"56","author":"Buchan","year":"1978","journal-title":"Histochemistry"},{"key":"10.1016\/j.molmet.2025.102118_bib83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF00499706","article-title":"Identification of the intestinal cell storing gastric inhibitory peptide","volume":"43","author":"Buffa","year":"1975","journal-title":"Histochemistry"},{"key":"10.1016\/j.molmet.2025.102118_bib84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0167-0115(03)00125-3","article-title":"GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine","volume":"114","author":"Mortensen","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0026-0495(97)90251-1","article-title":"Incretin hormone expression in the gut of diabetic mice and rats","volume":"46","author":"Berghofer","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib86","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1073\/pnas.90.5.1992","article-title":"Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat","volume":"90","author":"Tseng","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib87","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.24.2.114","article-title":"Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine","volume":"24","author":"Bryant","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2025.102118_bib88","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/gut.20.8.653","article-title":"Distribution of the gut hormones in the primate intestinal tract","volume":"20","author":"Bryant","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2025.102118_bib89","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cell.2020.04.036","article-title":"High-resolution mRNA and secretome atlas of human enteroendocrine cells","volume":"181","author":"Beumer","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2025.102118_bib90","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molmet.2019.09.001","article-title":"Single cell transcriptomic profiling of large intestinal enteroendocrine cells in mice - identification of selective stimuli for insulin-like peptide-5 and glucagon-like peptide-1 co-expressing cells","volume":"29","author":"Billing","year":"2019","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib91","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.molmet.2017.07.014","article-title":"Single-cell RNA-sequencing reveals a distinct population of proglucagon-expressing cells specific to the mouse upper small intestine","volume":"6","author":"Glass","year":"2017","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib92","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-017-4450-9","article-title":"Enteroendocrine K and L cells in healthy and type 2 diabetic individuals","volume":"61","author":"Jorsal","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib93","first-page":"208","article-title":"Effect of fifty percent small bowel resection on gastric secretory function in rhesus monkeys","volume":"80","author":"Moossa","year":"1976","journal-title":"Surgery"},{"key":"10.1016\/j.molmet.2025.102118_bib94","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00000658-197707000-00011","article-title":"Effect of antrectomy on gastric hypersecretion induced by distal small bowel resection","volume":"186","author":"Hall","year":"1977","journal-title":"Ann Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-008-1202-x","article-title":"Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells","volume":"52","author":"Parker","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib96","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00422096","article-title":"Gastric inhibitory\u00a0polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy","volume":"12","author":"Creutzfeldt","year":"1976","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib97","first-page":"728","article-title":"Gastric acid secretion and gut hormone release in patients undergoing pancreaticoduodenectomy","volume":"99","author":"Sato","year":"1986","journal-title":"Surgery"},{"key":"10.1016\/j.molmet.2025.102118_bib98","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00125-020-05158-9","article-title":"The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial","volume":"63","author":"Juel","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/gut.18.2.121","article-title":"Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon","volume":"18","author":"Ebert","year":"1977","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2025.102118_bib100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<390::AID-DMRR67>3.0.CO;2-W","article-title":"Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1)","volume":"15","author":"Ranganath","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.molmet.2025.102118_bib101","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0167-0115(94)90199-6","article-title":"Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats","volume":"51","author":"Bryer-Ash","year":"1994","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-9610(78)90088-0","article-title":"Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion","volume":"135","author":"Sirinek","year":"1978","journal-title":"Am J Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib103","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1172\/JCI109100","article-title":"Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels","volume":"62","author":"Andersen","year":"1978","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01225454","article-title":"The incretin concept today","volume":"16","author":"Creutzfeldt","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/diab.29.2.140","article-title":"Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes","volume":"29","author":"Creutzfeldt","year":"1980","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1748-1716.1981.tb06811.x","article-title":"GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release","volume":"112","author":"Ahren","year":"1981","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.molmet.2025.102118_bib107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00495381","article-title":"Is GIP a glucagon cell constituent?","volume":"58","author":"Alumets","year":"1978","journal-title":"Histochemistry"},{"key":"10.1016\/j.molmet.2025.102118_bib108","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/aja.1001490410","article-title":"Immunocytochemical localization of a gastric imhibitory polypeptide-like material within A-cells of the endocrine pancreas","volume":"149","author":"Smith","year":"1977","journal-title":"Am J Anat"},{"key":"10.1016\/j.molmet.2025.102118_bib109","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1053\/j.gastro.2010.01.049","article-title":"Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet\u00a0alpha-cells and promotes insulin secretion","volume":"138","author":"Fujita","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib110","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/31.6.6188783","article-title":"Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera","volume":"31","author":"Sjolund","year":"1983","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.molmet.2025.102118_bib111","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2337\/db09-0035","article-title":"The expression and function of glucose-dependent insulinotropic polypeptide in the embryonic mouse pancreas","volume":"60","author":"Prasadan","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib112","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.bbagen.2015.02.006","article-title":"Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice","volume":"1850","author":"Moffett","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2025.102118_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096863","article-title":"Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy","volume":"9","author":"Moffett","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101005","article-title":"Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress","volume":"9","author":"Vasu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib115","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1007\/s00125-012-2716-9","article-title":"A\u00a0local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets","volume":"55","author":"Marchetti","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib116","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cmet.2017.02.008","article-title":"The role of pancreatic preproglucagon in glucose homeostasis in mice","volume":"25","author":"Chambers","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib117","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1021\/acs.jproteome.1c00463","article-title":"The human and mouse islet peptidome: effects of obesity and type 2 diabetes, and assessment of intraislet production of glucagon-like peptide-1","volume":"20","author":"Galvin","year":"2021","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.molmet.2025.102118_bib118","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1007\/s00125-016-4033-1","article-title":"Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets","volume":"59","author":"Adriaenssens","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib119","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","article-title":"Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes","volume":"4","author":"Fasolino","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101945","article-title":"Stimulating intestinal GIP release reduces food intake and body weight in mice","volume":"84","author":"Lewis","year":"2024","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib121","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/jnr.21349","article-title":"Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain","volume":"85","author":"Nyberg","year":"2007","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.molmet.2025.102118_bib122","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1523\/JNEUROSCI.4920-04.2005","article-title":"Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation","volume":"25","author":"Nyberg","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib123","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.tpj.6500346","article-title":"cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects","volume":"6","author":"Sondhi","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.molmet.2025.102118_bib124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0303-7207(95)03665-T","article-title":"Glucose-dependent insulinotropic peptide (GIP) gene expression in the rat salivary gland","volume":"115","author":"Tseng","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0303-7207(99)00106-9","article-title":"Glucose-dependent insulinotropic polypeptide gene expression in the stomach: revealed by a transgenic mouse study, in situ hybridization and immunohistochemical staining","volume":"154","author":"Yeung","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib126","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jc.2010-2435","article-title":"Impaired regulation of the incretin effect in patients with type 2 diabetes","volume":"96","author":"Bagger","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib127","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.regpep.2004.06.020","article-title":"Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes","volume":"122","author":"Nauck","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jcem-63-2-492","article-title":"Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses","volume":"63","author":"Nauck","year":"1986","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib130","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1172\/JCI105685","article-title":"Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects","volume":"46","author":"Perley","year":"1967","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib131","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/db18-1123","article-title":"Separate and combined glucometabolic effects of endogenous glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 in healthy individuals","volume":"68","author":"Gasbjerg","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib132","first-page":"E1049","article-title":"Effect of GIP and GLP-1 antagonists on insulin release in the rat","volume":"276","author":"Tseng","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib133","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diabetes.53.5.1326","article-title":"Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors","volume":"53","author":"Hansotia","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib134","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz175","article-title":"GIP and GLP-1 receptor antagonism during a meal in healthy individuals","volume":"105","author":"Gasbjerg","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib135","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","article-title":"Separate impact of obesity and glucose tolerance on the incretin effect\u00a0in\u00a0normal subjects and type 2 diabetic patients","volume":"57","author":"Muscelli","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib136","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1463-1326.2011.01549.x","article-title":"Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity","volume":"14","author":"Knop","year":"2012","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib137","doi-asserted-by":"crossref","first-page":"E774","DOI":"10.1152\/ajpendo.00496.2015","article-title":"The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?","volume":"310","author":"Aulinger","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib138","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2337\/db07-0100","article-title":"Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?","volume":"56","author":"Knop","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib139","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00125-006-0566-z","article-title":"Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus","volume":"50","author":"Knop","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib140","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2337\/db14-1751","article-title":"GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study","volume":"64","author":"Faerch","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib141","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/dc13-0465","article-title":"Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies","volume":"36","author":"Calanna","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib142","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","author":"Vilsboll","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib143","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/diabetes.53.3.654","article-title":"Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib144","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.regpep.2006.07.007","article-title":"The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects","volume":"137","author":"Vilsboll","year":"2006","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib146","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2002-021053","article-title":"Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib147","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/00365528509091657","article-title":"Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state","volume":"20","author":"Amland","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib148","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF00296993","article-title":"The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion","volume":"30","author":"Jones","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib149","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0026-0495(87)90153-3","article-title":"Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus","volume":"36","author":"Krarup","year":"1987","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib150","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.2337\/diabetes.50.11.2497","article-title":"Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes","volume":"50","author":"Meier","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib151","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","article-title":"Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients","volume":"45","author":"Vilsboll","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib152","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-0115(94)90136-8","article-title":"The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects","volume":"51","author":"Elahi","year":"1994","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib153","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/db20-0998","article-title":"Glucagonostatic potency of GLP-1 in patients with type 2 diabetes, patients\u00a0with type 1 diabetes, and healthy control subjects","volume":"70","author":"Bagger","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib154","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1210\/jc.2009-0921","article-title":"Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus","volume":"94","author":"Hare","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib155","first-page":"912","article-title":"Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations","volume":"76","author":"Nauck","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib156","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db10-1332","article-title":"GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes","volume":"60","author":"Mentis","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib157","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2362.1990.tb01896.x","article-title":"Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man","volume":"20","author":"Fuessl","year":"1990","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.molmet.2025.102118_bib158","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0167-0115(03)00111-3","article-title":"Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects","volume":"114","author":"Vilsboll","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib159","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00125-002-1028-x","article-title":"Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob\/ob) mice: evidence that GIP is the major physiological incretin","volume":"46","author":"Gault","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib160","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1210\/jc.2003-030738","article-title":"The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib161","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2007.07.002","article-title":"The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance","volume":"144","author":"Knop","year":"2007","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib162","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00572873","article-title":"Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation","volume":"30","author":"Nauck","year":"1993","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.molmet.2025.102118_bib163","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-13-0264","article-title":"Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty","volume":"169","author":"Plamboeck","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib164","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/diabetes.50.5.1004","article-title":"Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats","volume":"50","author":"Lynn","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2007.08.115","article-title":"Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat","volume":"362","author":"Piteau","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib166","first-page":"181","article-title":"Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors","volume":"26","author":"Younan","year":"2007","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.molmet.2025.102118_bib167","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1096\/fj.02-0243fje","article-title":"A\u00a0novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells","volume":"17","author":"Lynn","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.molmet.2025.102118_bib168","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/joe.0.1650281","article-title":"Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide","volume":"165","author":"Hinke","year":"2000","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib169","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/dom.12227","article-title":"Effects of chronic exposure of clonal beta-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1","volume":"16","author":"Pathak","year":"2014","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib170","doi-asserted-by":"crossref","first-page":"E538","DOI":"10.1152\/ajpendo.00070.2007","article-title":"Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets","volume":"293","author":"Zhou","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib171","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1152\/ajpendo.00358.2007","article-title":"A\u00a0novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice","volume":"294","author":"Harada","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib172","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jcem-42-5-791","article-title":"Gastric inhibitory polypeptide (GIP) in chronic pancreatitis","volume":"42","author":"Botha","year":"1976","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib173","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00125-008-1195-5","article-title":"Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes","volume":"52","author":"Hojberg","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib174","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/jc.2008-1731","article-title":"KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes","volume":"94","author":"Aaboe","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/dom.12395","article-title":"Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors","volume":"17","author":"Aaboe","year":"2015","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib176","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib177","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2025.102118_bib178","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib179","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.molmet.2025.102118_bib180","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/dom.14775","article-title":"Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: an adjusted indirect treatment comparison","volume":"24","author":"Vadher","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib181","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00125-018-4810-0","article-title":"Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight\/obese individuals: a randomised, crossover study","volume":"62","author":"Bergmann","year":"2019","journal-title":"Diabetologia"},{"issue":"Suppl 3","key":"10.1016\/j.molmet.2025.102118_bib182","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.2337\/diabetes.53.suppl_3.S220","article-title":"Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib183","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-5793(93)81493-J","article-title":"Two 3',5'-cyclic-adenosine monophosphate response elements in the promoter region of the human gastric inhibitory polypeptide gene","volume":"317","author":"Someya","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.molmet.2025.102118_bib184","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0742-8413(94)00087-Q","article-title":"Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine","volume":"110","author":"Higashimoto","year":"1995","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib185","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1073\/pnas.89.3.1045","article-title":"c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements","volume":"89","author":"Inagaki","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib186","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1210\/en.2004-0051","article-title":"Minireview: development and differentiation of gut endocrine cells","volume":"145","author":"Schonhoff","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036449","article-title":"The homeodomain-containing transcription factors Arx and Pax4 control enteroendocrine subtype specification in mice","volume":"7","author":"Beucher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib188","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ydbio.2006.07.020","article-title":"Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expression","volume":"298","author":"Boyer","year":"2006","journal-title":"Dev Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib189","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1210\/en.2004-0223","article-title":"Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1","volume":"146","author":"Jepeal","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0925-4773(98)00182-8","article-title":"Pax 4 and 6 regulate gastrointestinal endocrine cell development","volume":"79","author":"Larsson","year":"1998","journal-title":"Mech Dev"},{"key":"10.1016\/j.molmet.2025.102118_bib191","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1074\/jbc.M112.423137","article-title":"Transcriptional regulatory factor X6 (Rfx6) increases gastric inhibitory polypeptide (GIP) expression in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity","volume":"288","author":"Suzuki","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib192","doi-asserted-by":"crossref","first-page":"G272","DOI":"10.1152\/ajpgi.00054.2018","article-title":"Transcriptional factor Pdx1 is involved in age-related GIP hypersecretion in mice","volume":"315","author":"Ikeguchi","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib193","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1464-5491.2000.00236.x","article-title":"Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose","volume":"17","author":"Meneilly","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.molmet.2025.102118_bib194","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s001250051070","article-title":"The ageing entero-insular axis","volume":"41","author":"Ranganath","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-0115(03)00046-6","article-title":"Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene functions through a GATA and an ISL-1 motif in a mouse neuroendocrine tumor cell line","volume":"113","author":"Jepeal","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib196","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2008.01.024","article-title":"GATA-4 upregulates glucose-dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineage","volume":"287","author":"Jepeal","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib197","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41467-017-00895-9","article-title":"Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance","volume":"8","author":"Patel","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib198","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0002-9610(75)90360-8","article-title":"Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances","volume":"130","author":"Cleator","year":"1975","journal-title":"Am J Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib199","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/jcem-41-2-260","article-title":"Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man","volume":"41","author":"Falko","year":"1975","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib200","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diab.24.12.1050","article-title":"Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog","volume":"24","author":"Pederson","year":"1975","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib201","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0742-8413(95)00046-1","article-title":"GIP and GLP-1(7-36)amide secretion in response to intraduodenal infusions of nutrients in pigs","volume":"111","author":"Knapper","year":"1995","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.1984.tb03461.x","article-title":"Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man","volume":"21","author":"Lucey","year":"1984","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00252263","article-title":"Effect of co-ingestion of fat on the metabolic responses to slowly and rapidly absorbed carbohydrates","volume":"26","author":"Collier","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib204","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00422937","article-title":"Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-1-diabetic patients after successful combined pancreas and kidney transplantation","volume":"70","author":"Nauck","year":"1992","journal-title":"Clin Invest"},{"key":"10.1016\/j.molmet.2025.102118_bib205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00006676-199407000-00018","article-title":"Neural modulation of glucose-dependent insulinotropic peptide (GIP) and insulin secretion in conscious dogs","volume":"9","author":"Greenberg","year":"1994","journal-title":"Pancreas"},{"key":"10.1016\/j.molmet.2025.102118_bib206","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ajcn\/68.3.591","article-title":"Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate","volume":"68","author":"Lavin","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib207","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/BF01072882","article-title":"Mannitol and glucose: effects on gastric acid secretion and endogenous gastric inhibitory polypeptide (GIP)","volume":"23","author":"O'Dorisio","year":"1978","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.molmet.2025.102118_bib208","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1620\/tjem.147.183","article-title":"Role of vagus nerve in secretion of gastric inhibitory polypeptide in dogs","volume":"147","author":"Ohneda","year":"1985","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.molmet.2025.102118_bib209","first-page":"2367","article-title":"An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats","volume":"122","author":"Fushiki","year":"1992","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib210","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbrc.2013.12.093","article-title":"Reprogramming of enteroendocrine K cells to pancreatic beta-cells through the combined expression of Nkx6.1 and Neurogenin3, and reaggregation in suspension culture","volume":"443","author":"Lee","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib211","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1126\/science.290.5498.1959","article-title":"Glucose-dependent insulin release from genetically engineered K cells","volume":"290","author":"Cheung","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102118_bib212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1139\/o71-037","article-title":"A\u00a0gastric inhibitory polypeptide. I. The amino acid composition and the tryptic peptides","volume":"49","author":"Brown","year":"1971","journal-title":"Can J Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib213","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1139\/o71-122","article-title":"A\u00a0gastric inhibitory polypeptide. II. The complete amino acid sequence","volume":"49","author":"Brown","year":"1971","journal-title":"Can J Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib214","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-5793(81)80288-8","article-title":"Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)","volume":"123","author":"Jornvall","year":"1981","journal-title":"FEBS Lett"},{"key":"10.1016\/j.molmet.2025.102118_bib215","doi-asserted-by":"crossref","first-page":"G608","DOI":"10.1152\/ajpgi.00024.2010","article-title":"Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut","volume":"298","author":"Fujita","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib216","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1074\/jbc.M601203200","article-title":"Prohormone convertase 1\/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor","volume":"281","author":"Ugleholdt","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib217","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0167-4781(96)00103-0","article-title":"Isolation of a murine glucose-dependent insulinotropic polypeptide (GIP) cDNA from a tumor cell line (STC6-14) and quantification of glucose-induced increases in GIP mRNA","volume":"1308","author":"Schieldrop","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2025.102118_bib218","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1073\/pnas.84.20.7005","article-title":"Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor","volume":"84","author":"Takeda","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib219","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0167-4781(92)90054-4","article-title":"Molecular cloning of rat glucose-dependent insulinotropic peptide (GIP)","volume":"1132","author":"Higashimoto","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2025.102118_bib220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1677\/jme.0.0090265","article-title":"Characterization of rat gastric inhibitory peptide cDNA","volume":"9","author":"Sharma","year":"1992","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib221","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/bbrc.1993.1607","article-title":"Isolation and characterization of the gene encoding rat glucose-dependent insulinotropic peptide","volume":"193","author":"Higashimoto","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib222","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1210\/mend-3-6-1014","article-title":"Gastric inhibitory polypeptide: structure and chromosomal localization of the human gene","volume":"3","author":"Inagaki","year":"1989","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib223","first-page":"385","article-title":"Evolution of the vertebrate glucose-dependent insulinotropic polypeptide (GIP) gene","volume":"1","author":"Irwin","year":"2006","journal-title":"Comp Biochem Physiol, Part D: Genomics Proteomics"},{"key":"10.1016\/j.molmet.2025.102118_bib224","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00125-015-3842-y","article-title":"Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice","volume":"59","author":"Yanagimachi","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib225","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00543956","article-title":"A\u00a0comparison of the ability of serum and monoclonal antibodies to gastric inhibitory polypeptide to detect immunoreactive cells in the gastroenteropancreatic system of mammals and reptiles","volume":"76","author":"Buchan","year":"1982","journal-title":"Histochemistry"},{"key":"10.1016\/j.molmet.2025.102118_bib226","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2337\/db15-1541","article-title":"Evidence of extrapancreatic glucagon secretion in man","volume":"65","author":"Lund","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib227","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050710","article-title":"Novel homozygous inactivating mutation in the PCSK1 gene in an infant with congenital malabsorptive diarrhea","volume":"12","author":"Aerts","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.molmet.2025.102118_bib228","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-4838(01)00181-9","article-title":"Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP)","volume":"1547","author":"Hinke","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2025.102118_bib229","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0196-9781(95)00090-7","article-title":"Characterization of GIP(1-30) and GIP(1-42) as stimulators of proinsulin gene transcription","volume":"16","author":"Fehmann","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib230","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvac015","article-title":"The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans","volume":"188","author":"Krogh","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib231","article-title":"Establishment of novel specific assay for short-form glucose-dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects","volume":"8","author":"Takeda","year":"2020","journal-title":"Phys Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib232","first-page":"265","article-title":"Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed mice","volume":"208","author":"Gault","year":"2011","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib233","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1210\/endo-120-2-835","article-title":"Commercially available preparations of porcine glucose-dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP-fragment and cholecystokinin-33\/-39","volume":"120","author":"Schmidt","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib234","article-title":"N-terminal tyrosine-alanine is required for the insulin-releasing activity of glucose-dependent insulinotropic polypeptide (GIP","volume":"A9","author":"Schmidt","year":"1986","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.molmet.2025.102118_bib235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib236","doi-asserted-by":"crossref","first-page":"23222","DOI":"10.1074\/jbc.271.38.23222","volume":"271","author":"Pauly","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib237","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in\u00a0vitro and in\u00a0vivo by dipeptidyl peptidase IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib238","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1073\/pnas.120069197","article-title":"Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26","volume":"97","author":"Marguet","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib239","first-page":"3575","article-title":"Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide","volume":"85","author":"Deacon","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib240","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/diabetes.50.7.1588","article-title":"Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs","volume":"50","author":"Deacon","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib241","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1210\/jc.2006-1009","article-title":"Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes","volume":"91","author":"Herman","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib242","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s001250050903","article-title":"Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity","volume":"41","author":"Deacon","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib243","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/00365528109182000","article-title":"Removal of IR-GIP by the kidneys in man, and the effect of acute nephrectomy on plasma GIP in rats","volume":"16","author":"Jorde","year":"1981","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib244","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ndt\/gft353","article-title":"Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease","volume":"29","author":"Idorn","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.molmet.2025.102118_bib245","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1210\/jc.2013-3809","article-title":"Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease","volume":"99","author":"Idorn","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib246","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0002-9610(84)90426-4","article-title":"Chronic renal failure: effect\u00a0of hemodialysis on gastrointestinal hormones","volume":"148","author":"Sirinek","year":"1984","journal-title":"Am J Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib247","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0026-0495(77)90086-5","article-title":"Renal effects on serum gastric inhibitory polypeptide (GIP)","volume":"26","author":"O'Dorisio","year":"1977","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib248","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF01297054","article-title":"Absence of hepatic extraction of gastric inhibitory polypeptide in conscious dogs","volume":"32","author":"Chap","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib249","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1210\/endo-115-3-1011","article-title":"The hepatic extraction of gastric inhibitory polypeptide and insulin","volume":"115","author":"Hanks","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib250","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1016\/S0021-9258(19)70701-7","article-title":"Biogenesis of plasma membrane glycoproteins. Purification and properties of two rat liver plasma membrane glycoproteins","volume":"255","author":"Elovson","year":"1980","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib251","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1152\/ajpendo.00577.2005","article-title":"GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations","volume":"291","author":"Deacon","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib252","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1677\/joe.0.1750525","article-title":"Evidence that the major\u00a0degradation product of glucose-dependent insulinotropic polypeptide,\u00a0GIP(3-42), is a GIP receptor antagonist in\u00a0vivo","volume":"175","author":"Gault","year":"2002","journal-title":"J\u00a0Endocrinol"},{"issue":"3","key":"10.1016\/j.molmet.2025.102118_bib253","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/clinem\/dgae583","article-title":"GIP receptor antagonism eliminates paradoxical growth hormone secretion in some patients with acromegaly","volume":"110","author":"Jensen","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171254","article-title":"Chronic exposure\u00a0to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice","volume":"178","author":"Sridhar","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib255","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","article-title":"Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects","volume":"44","author":"Deacon","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-291X(02)00359-5","article-title":"Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective","volume":"294","author":"Deacon","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib257","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-291X(02)00753-2","article-title":"Rebuttal to Deacon and Holst: \"Metformin effects on dipeptidyl peptidase IV degradation of glucagon-like peptide-1\" versus \"Dipeptidyl peptidase inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective\"","volume":"296","author":"Demuth","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib258","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.2337\/db16-0107","article-title":"Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and patients with type 2 diabetes using exendin [9-39] as a GLP-1 receptor antagonist","volume":"65","author":"Nauck","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib259","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molmet.2016.12.009","article-title":"Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects","volume":"6","author":"Yanagimachi","year":"2017","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib260","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.2337\/db07-0697","article-title":"Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice","volume":"56","author":"Flock","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib261","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1007\/s00125-019-4963-5","article-title":"The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice","volume":"62","author":"Hutch","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib262","first-page":"2209","article-title":"Endogenous glucose-dependent insulinotropic polypeptide contributes to sitagliptin-mediated improvement in beta-cell function in patients with type 2 diabetes","volume":"71","author":"Stensen","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib263","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0304-4165(98)00084-1","article-title":"Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cells","volume":"1425","author":"O'Harte","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2025.102118_bib264","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2337\/diabetes.48.4.758","article-title":"NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity","volume":"48","author":"O'Harte","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib265","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/bj20020319","article-title":"Enhanced cAMP generation and insulin-releasing potency of two novel Tyr1-modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with significant antihyperglycaemic activity in spontaneous obesity-diabetes","volume":"367","author":"Gault","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib266","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0026-0495(03)00027-1","article-title":"Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in\u00a0vivo","volume":"52","author":"Gault","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib267","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00125-002-0894-6","article-title":"Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP","volume":"45","author":"O'Harte","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib268","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1677\/joe.0.1650639","article-title":"Improved glycaemic control in obese diabetic ob\/ob mice using N-terminally modified gastric inhibitory polypeptide","volume":"165","author":"O'Harte","year":"2000","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib269","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.abb.2007.03.001","article-title":"Characterisation and biological activity of Glu3 amino acid substituted GIP receptor antagonists","volume":"461","author":"Gault","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.molmet.2025.102118_bib270","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1006\/bbrc.2002.6364","article-title":"Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide","volume":"290","author":"Gault","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib271","doi-asserted-by":"crossref","first-page":"E1674","DOI":"10.1152\/ajpendo.00391.2006","article-title":"Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob\/ob mice","volume":"292","author":"O'Harte","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib272","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diabetes.54.8.2436","article-title":"Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes","volume":"54","author":"Gault","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib273","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/diabetes.51.3.652","article-title":"Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats","volume":"51","author":"Hinke","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib274","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/0-306-47920-6_35","article-title":"Glucose-dependent insulinotropic polypeptide (GIP): development of DP IV-resistant analogues with therapeutic potential","volume":"524","author":"Hinke","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib275","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1074\/jbc.M311304200","article-title":"[Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in\u00a0vitro and in\u00a0vivo","volume":"279","author":"Hinke","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib276","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.bcp.2008.03.011","article-title":"C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes","volume":"75","author":"Gault","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib277","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bcp.2006.06.013","article-title":"Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide","volume":"72","author":"Irwin","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib278","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1515\/BC.2005.079","article-title":"Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37)","volume":"386","author":"Irwin","year":"2005","journal-title":"Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib279","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.peptides.2005.08.003","article-title":"Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice","volume":"27","author":"Irwin","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib280","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1021\/jm049262s","article-title":"Degradation, insulin secretion, and antihyperglycemic actions of two palmitate-derivitized N-terminal pyroglutamyl analogues of glucose-dependent insulinotropic polypeptide","volume":"48","author":"Irwin","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib281","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1124\/jpet.105.086082","article-title":"A\u00a0novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetes","volume":"314","author":"Irwin","year":"2005","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.molmet.2025.102118_bib282","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/jm0509997","article-title":"GIP(Lys16PAL) and GIP(Lys37PAL): novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potential","volume":"49","author":"Irwin","year":"2006","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib283","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bcp.2009.05.037","article-title":"Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties","volume":"78","author":"Kerr","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib284","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.bbagen.2013.03.011","article-title":"A\u00a0novel acylated form of (d-Ala(2))GIP with improved antidiabetic potential, lacking effect on body fat stores","volume":"1830","author":"Martin","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2025.102118_bib285","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bjp.2008.317","article-title":"(Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy","volume":"155","author":"McClean","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib286","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/dom.12181","article-title":"A\u00a0novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents","volume":"16","author":"Tatarkiewicz","year":"2014","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib287","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/CS20110006","article-title":"Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity","volume":"121","author":"Gault","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.molmet.2025.102118_bib288","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/dmrr.729","article-title":"Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob\/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide","volume":"23","author":"Irwin","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.molmet.2025.102118_bib289","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/psc.861","article-title":"Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob\/ob) mice","volume":"13","author":"Irwin","year":"2007","journal-title":"J\u00a0Pept Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib290","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bcp.2018.07.021","article-title":"Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential","volume":"155","author":"Pathak","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib291","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bcp.2013.03.009","article-title":"A\u00a0novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties","volume":"85","author":"Bhat","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib292","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00125-013-2892-2","article-title":"A\u00a0DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice","volume":"56","author":"Bhat","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib293","doi-asserted-by":"crossref","first-page":"35581","DOI":"10.1074\/jbc.M113.512046","article-title":"A\u00a0novel glucagon-like peptide-1 (GLP-1)\/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice","volume":"288","author":"Gault","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib294","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nchembio.209","article-title":"A\u00a0new glucagon and GLP-1 co-agonist eliminates obesity in rodents","volume":"5","author":"Day","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A\u00a0rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib296","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0016-5085(74)80134-4","article-title":"Radioimmunoassay for gastric inhibitory polypeptide","volume":"66","author":"Kuzio","year":"1974","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib297","first-page":"1095","article-title":"Fasting and postprandial GIP values in pigs, rats, dogs, and man measured with five different GIP antisera","volume":"19","author":"Amland","year":"1984","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib298","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0167-0115(83)90283-5","article-title":"Fasting and postprandial plasma GIP values in man measured with seven different antisera","volume":"7","author":"Jorde","year":"1983","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib299","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0167-0115(84)90005-3","article-title":"The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera","volume":"9","author":"Krarup","year":"1984","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib300","first-page":"E195","article-title":"Responses and molecular heterogeneity of\u00a0IR-GIP after intraduodenal glucose and fat","volume":"249","author":"Krarup","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib301","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00365519209088772","article-title":"The reactivity of anti-porcine gastric inhibitory polypeptide (GIP) rabbit serum R65 with synthetic human and porcine GIP","volume":"52","author":"Moody","year":"1992","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.molmet.2025.102118_bib302","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/000456327801500138","article-title":"Radioimmunoassay of gastric inhibitory polypeptide","volume":"15","author":"Morgan","year":"1978","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib303","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1210\/jcem-56-6-1306","article-title":"Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics","volume":"56","author":"Krarup","year":"1983","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib304","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00365529609009147","article-title":"Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day","volume":"31","author":"Orskov","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib305","first-page":"939","article-title":"The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man","volume":"14","author":"Burhol","year":"1979","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib306","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1210\/endo.133.1.8319572","article-title":"Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop","volume":"133","author":"Roberge","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib307","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/endo-128-6-3175","article-title":"Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides","volume":"128","author":"Brubaker","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib308","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/endo.140.4.6643","article-title":"Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion","volume":"140","author":"Rocca","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib309","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/jdi.13962","article-title":"Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: characteristics and regulation","volume":"14","author":"Alsalim","year":"2023","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib310","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00125-014-3305-x","article-title":"Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial","volume":"57","author":"Jakubowicz","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib311","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2337\/dc09-0723","article-title":"Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes","volume":"32","author":"Ma","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib312","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.2040-1124.2010.00010.x","article-title":"Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: comparison of type 2 diabetes patients and healthy controls","volume":"1","author":"Yabe","year":"2010","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib313","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1348146","article-title":"Motilin fluctuations in healthy volunteers determined by liquid chromatography mass spectrometry","volume":"15","author":"Foreman","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib314","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib315","doi-asserted-by":"crossref","first-page":"E779","DOI":"10.1152\/ajpendo.90233.2008","article-title":"Incretin and islet hormonal responses to fat and protein ingestion in healthy men","volume":"295","author":"Carr","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib316","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/BF01117003","article-title":"Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob\/ob) mice","volume":"5","author":"Kwasowski","year":"1985","journal-title":"Biosci Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib317","first-page":"1300","article-title":"Stimulation of gastric inhibitory polypeptide release in ob\/ob mice by oral administration of sugars and their analogues","volume":"119","author":"Flatt","year":"1989","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib318","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jdi.13836","article-title":"Glucose-dependent insulinotropic polypeptide secretion after oral macronutrient ingestion: the human literature revisited and a systematic study in model experiments in mice","volume":"13","author":"Ahren","year":"2022","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib319","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1677\/joe.0.0850487","article-title":"A\u00a0radioimmunoassay of gastric inhibitory polypeptide in human plasma","volume":"85","author":"Sarson","year":"1980","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib320","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01073027","article-title":"Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides","volume":"21","author":"O'Dorisio","year":"1976","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.molmet.2025.102118_bib321","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0016-5085(76)80489-1","article-title":"Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion","volume":"70","author":"Thomas","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib322","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0016-5085(78)90703-5","article-title":"Selective release of gastric inhibitory polypeptide by intraduodenal amino acid perfusion in man","volume":"74","author":"Thomas","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib323","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00394-004-0448-4","article-title":"Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans","volume":"43","author":"Calbet","year":"2004","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib324","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2014-3865","article-title":"Incretin effect after oral amino acid ingestion in humans","volume":"100","author":"Lindgren","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib325","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0016-5085(82)80018-8","article-title":"Release of gastric inhibitory peptide following a peptone meal in the dog","volume":"83","author":"Wolfe","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib326","doi-asserted-by":"crossref","first-page":"G561","DOI":"10.1152\/ajpgi.2000.279.3.G561","article-title":"Regulation of glucose-dependent insulinotropic polypeptide release by protein in the rat","volume":"279","author":"Wolfe","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib327","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.0.1010249","article-title":"Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob\/ob) mice","volume":"101","author":"Flatt","year":"1984","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib328","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/diab.32.5.433","article-title":"Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice","volume":"32","author":"Flatt","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib329","first-page":"1123","article-title":"Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycemic (ob\/ob) mice","volume":"121","author":"Flatt","year":"1991","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib330","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1677\/joe.0.0850201","article-title":"Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues","volume":"85","author":"Sykes","year":"1980","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib331","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jdi.12356","article-title":"Fructose induces glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and insulin secretion: role of adenosine triphosphate-sensitive K(+) channels","volume":"6","author":"Seino","year":"2015","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib332","doi-asserted-by":"crossref","first-page":"G622","DOI":"10.1152\/ajpgi.00372.2013","article-title":"Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans","volume":"306","author":"Kuhre","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib333","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0026-0495(81)90215-8","article-title":"Determinants of gastric inhibitory polypeptide and insulin secretion","volume":"30","author":"Williams","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib334","doi-asserted-by":"crossref","first-page":"G735","DOI":"10.1152\/ajpgi.90708.2008","article-title":"Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects","volume":"296","author":"Ma","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3945\/ajcn.111.021543","article-title":"Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans","volume":"95","author":"Wu","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib336","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2016-1133","article-title":"Cholecystokinin-induced gallbladder emptying and metformin elicit additive glucagon-like peptide-1 responses","volume":"101","author":"Rohde","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib337","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/endo.136.12.7588313","article-title":"Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures","volume":"136","author":"Rocca","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib338","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/69.6.1135","article-title":"Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects","volume":"69","author":"Thomsen","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib339","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0016-5085(81)90199-2","article-title":"The importance of triglyceride hydrolysis for the release of gastric inhibitory polypeptide","volume":"80","author":"Ross","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib340","first-page":"224","article-title":"Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob\/ob) mice fed high fat and high carbohydrate cafeteria diets","volume":"112","author":"Bailey","year":"1986","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib341","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/bmj.2.6200.1252","article-title":"Gut hormones in tropical malabsorption","volume":"2","author":"Besterman","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.molmet.2025.102118_bib342","first-page":"578","article-title":"Postprandial lipid and hormone responses to meals of varying fat contents: modulatory role of lipoprotein lipase?","volume":"49","author":"Murphy","year":"1995","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib343","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jc.2010-2435","article-title":"Impaired regulation of the incretin effect in patients with type 2 diabetes","volume":"96","author":"Bagger","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib344","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1079\/BJN19850056","article-title":"The effect of guar gum on carbohydrate-, fat- and protein-stimulated gut hormone secretion: modification of postprandial gastric inhibitory polypeptide and gastrin responses","volume":"53","author":"Morgan","year":"1985","journal-title":"Br J Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib345","doi-asserted-by":"crossref","DOI":"10.3390\/nu11010082","article-title":"Appetite and gastrointestinal hormone response to a gluten-free meal in patients with coeliac disease","volume":"11","author":"Vitaglione","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.molmet.2025.102118_bib346","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/JOE-14-0161","article-title":"KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state","volume":"222","author":"Ogata","year":"2014","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib347","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030883","article-title":"Nutrient-induced cellular mechanisms of gut hormone secretion","volume":"13","author":"Lu","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.molmet.2025.102118_bib348","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/0006-291X(91)92067-T","article-title":"Distribution of the SGLT1 Na+\/glucose cotransporter and mRNA along the crypt-villus axis of rabbit small intestine","volume":"181","author":"Hwang","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib349","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/BF02389029","article-title":"Immunohistochemical localization of Na(+)-dependent glucose transporter in the rat digestive tract","volume":"27","author":"Yoshida","year":"1995","journal-title":"Histochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib350","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170206","article-title":"Cellular mechanisms governing glucose-dependent insulinotropic polypeptide secretion","volume":"125","author":"Reimann","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib351","first-page":"E489","article-title":"Release of gastric inhibitory polypeptide from cultured canine endocrine cells","volume":"267","author":"Kieffer","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib352","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s00125-012-2663-5","article-title":"Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents","volume":"55","author":"Moss","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib353","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/db11-1029","article-title":"Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion","volume":"61","author":"Gorboulev","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib354","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/dom.13654","article-title":"The\u00a0effects of licogliflozin, a dual SGLT1\/2 inhibitor, on body weight in obese patients with or without diabetes","volume":"21","author":"He","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib355","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcp.10139","article-title":"Novel insulin\/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in\u00a0vivo","volume":"192","author":"Ramshur","year":"2002","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib356","doi-asserted-by":"crossref","first-page":"E988","DOI":"10.1152\/ajpendo.00398.2002","article-title":"Studies with GIP\/Ins cells indicate secretion by gut K cells is KATP channel independent","volume":"284","author":"Wang","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib357","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1210\/jc.2006-1932","article-title":"The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion","volume":"92","author":"El-Ouaghlidi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib358","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.diabres.2011.07.014","article-title":"Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus","volume":"94","author":"Stephens","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.molmet.2025.102118_bib359","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/eje.0.1510407","article-title":"Gastric inhibitory polypeptide is the major insulinotropic factor in K(ATP) null mice","volume":"151","author":"Tsukiyama","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib360","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170206","article-title":"Cellular mechanisms governing glucose-dependent insulinotropic polypeptide secretion","volume":"125","author":"Reimann","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib361","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.1172256","article-title":"The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102118_bib362","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/00365529509101597","article-title":"Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose)","volume":"30","author":"Qualmann","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib363","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y","article-title":"Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients","volume":"15","author":"Seifarth","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.molmet.2025.102118_bib364","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000201282","article-title":"Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve","volume":"56","author":"G\u00f6ke","year":"1995","journal-title":"Digestion"},{"key":"10.1016\/j.molmet.2025.102118_bib365","first-page":"G493","article-title":"Liver extract and its free amino acids equally stimulate gastric acid secretion","volume":"239","author":"Feldman","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib366","first-page":"G429","article-title":"Importance of food in the regulation of gastrin release and formation","volume":"243","author":"Lichtenberger","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib367","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/295698a0","article-title":"Importance of amino acid uptake and decarboxylation in gastrin release from isolated G cells","volume":"295","author":"Lichtenberger","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib368","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/00365528109182011","article-title":"Radioimmunoassay of gastric inhibitory polypeptide (GIP) and\u00a0the\u00a0effect of intraduodenal acidification on glucose-stimulated and\u00a0unstimulated GIP release in humans","volume":"16","author":"Flaten","year":"1981","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib369","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0016-5085(79)80219-X","article-title":"Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats","volume":"76","author":"Ebert","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib370","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1210\/jcem-51-6-1385","article-title":"Acid-induced gastric inhibitory polypeptide secretion in man","volume":"51","author":"LeRoith","year":"1980","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib371","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2018.10.012","article-title":"The aromatic amino acid sensor GPR142 controls metabolism through balanced regulation of pancreatic and gut hormones","volume":"19","author":"Rudenko","year":"2019","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib372","doi-asserted-by":"crossref","DOI":"10.3390\/ani9080476","article-title":"L-Phenylalanine increased gut hormone secretion through calcium-sensing receptor in the porcine duodenum","volume":"9","author":"Feng","year":"2019","journal-title":"Animals"},{"key":"10.1016\/j.molmet.2025.102118_bib373","first-page":"G925","article-title":"Gastric emptying of oil and aqueous meal components in pancreatic insufficiency: effects of posture and on appetite","volume":"268","author":"Carney","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib374","doi-asserted-by":"crossref","first-page":"G482","DOI":"10.1152\/ajpgi.90209.2008","article-title":"Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects","volume":"296","author":"Enc","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib375","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1210\/jc.2003-030199","article-title":"Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil\/aqueous drink in type 2 diabetes mellitus","volume":"88","author":"Pilichiewicz","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib376","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s00125-017-4420-2","article-title":"Chylomicrons stimulate incretin secretion in mouse and human cells","volume":"60","author":"Psichas","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib377","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1210\/en.2008-1162","article-title":"Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL\/6J mice","volume":"150","author":"Shimotoyodome","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib378","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11745-011-3650-1","article-title":"Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP","volume":"47","author":"Lu","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.molmet.2025.102118_bib379","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2009.08.167","article-title":"Role of MGAT2 and DGAT1 in the release of gut peptides after triglyceride ingestion","volume":"390","author":"Okawa","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib380","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/db08-0307","article-title":"Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion","volume":"57","author":"Edfalk","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib381","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/en.2014-1653","article-title":"Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion","volume":"156","author":"Iwasaki","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib382","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/jdi.13059","article-title":"Free fatty acid receptors, G protein-coupled receptor 120 and G protein-coupled receptor 40, are essential for oil-induced gastric inhibitory polypeptide secretion","volume":"10","author":"Sankoda","year":"2019","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib383","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121475","article-title":"Incretins play an important role in FFA4\/GPR120 regulation of glucose metabolism by GW-9508","volume":"318","author":"McKillop","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib384","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib385","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib386","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/164_2016_46","article-title":"Gut hormone regulation and secretion via FFA1 and FFA4","volume":"236","author":"Gribble","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib387","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tips.2012.03.014","article-title":"GPR119 as a fat sensor","volume":"33","author":"Hansen","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib388","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","article-title":"Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor","volume":"326","author":"Soga","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib389","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/en.2017-00090","article-title":"Long-chain free fatty acid receptor GPR120 mediates oil-induced GIP secretion through CCK in male mice","volume":"158","author":"Sankoda","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib390","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1210\/en.2016-1334","article-title":"GPR119, a major enteroendocrine sensor of dietary triglyceride metabolites coacting in synergy with FFA1 (GPR40)","volume":"157","author":"Ekberg","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib391","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105104","article-title":"Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis","volume":"142","author":"McCloskey","year":"2020","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib392","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/JOE-08-0453","article-title":"GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis","volume":"201","author":"Lan","year":"2009","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib393","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2014.10.002","article-title":"GPR40 (FFAR1) - combined Gs and Gq signaling in\u00a0vitro is associated with robust incretin secretagogue action ex\u00a0vivo and in\u00a0vivo","volume":"4","author":"Hauge","year":"2015","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib394","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101757","article-title":"Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2","volume":"74","author":"Petersen","year":"2023","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib395","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170251","article-title":"CRISPR\/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function","volume":"125","author":"McCloskey","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib396","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1007\/s00125-016-4108-z","article-title":"Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice","volume":"59","author":"McKillop","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib397","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/JME-15-0293","article-title":"Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells","volume":"56","author":"Kuhre","year":"2016","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"Pt 1","key":"10.1016\/j.molmet.2025.102118_bib398","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1469-7793.1998.011by.x","article-title":"Fatty acids stimulate cholecystokinin secretion via an acyl chain length-specific, Ca2+-dependent mechanism in the enteroendocrine cell line STC-1","volume":"513","author":"McLaughlin","year":"1998","journal-title":"J\u00a0Physiol"},{"issue":"528 Pt","key":"10.1016\/j.molmet.2025.102118_bib399","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1469-7793.2000.00165.x","article-title":"Fatty acid-induced cholecystokinin secretion and changes in intracellular Ca2+ in two enteroendocrine cell lines, STC-1 and GLUTag","volume":"1","author":"Sidhu","year":"2000","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib400","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1152\/ajpendo.00543.2014","article-title":"Fatty acid-binding protein 5 regulates diet-induced obesity via GIP secretion from enteroendocrine K cells in response to fat ingestion","volume":"308","author":"Shibue","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib401","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00275269","article-title":"Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution","volume":"19","author":"Ebert","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib402","first-page":"E 324","article-title":"Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution","volume":"292","author":"Knop","year":"2007","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib403","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-12-381517-0.00006-0","article-title":"Central regulation of glucose-dependent insulinotropic polypeptide secretion","volume":"84","author":"Yavropoulou","year":"2010","journal-title":"Vitam Horm"},{"key":"10.1016\/j.molmet.2025.102118_bib404","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1152\/ajpgi.00222.2015","article-title":"Cephalic phase secretion of insulin and other enteropancreatic hormones\u00a0in\u00a0humans","volume":"310","author":"Veedfald","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib405","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s001250051322","article-title":"Autonomic regulation of islet hormone secretion--implications for health and disease","volume":"43","author":"Ahren","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib406","first-page":"R615","article-title":"Parasympathetic involvement in rapid meal-associated conditioned insulin secretion in the rat","volume":"263","author":"Strubbe","year":"1992","journal-title":"Am J Physiol"},{"issue":"Pt 2","key":"10.1016\/j.molmet.2025.102118_bib407","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/bj2880357","article-title":"Oscillations of cytosolic free calcium concentration in the presence of intracellular antibodies to phosphatidylinositol 4,5-bisphosphate in voltage-clamped Guinea-pig hepatocytes","volume":"288","author":"Noel","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib408","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0196-9781(82)90059-6","article-title":"Lack of gastric inhibitory polypeptide\u00a0(GIP) response to vagal stimulation in the rat","volume":"3","author":"Berthoud","year":"1982","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib409","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1210\/jcem-55-6-1198","article-title":"Pubertal endocrinology of the baboon: elevated somatomedin-C\/insulin-like growth factor I at puberty","volume":"55","author":"Copeland","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib410","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/BF01303213","article-title":"Lack of a direct effect of the autonomic nervous system on glucose-stimulated gastric inhibitory polypeptide (GIP) secretion in man","volume":"31","author":"Nelson","year":"1986","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib411","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF01654771","article-title":"Effect of vagotomy on gastrointestinal hormones","volume":"3","author":"Becker","year":"1979","journal-title":"World J Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib412","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1620\/tjem.151.97","article-title":"Glucose-induced responses of insulin and gastric inhibitory polypeptide in various animal models","volume":"151","author":"Ohneda","year":"1987","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.molmet.2025.102118_bib413","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/00365528209182240","article-title":"Release of gastric inhibitory polypeptide and insulin in response to intrajejunal glucose in duodenal ulcer patients before and after truncal vagotomy","volume":"17","author":"Lauritsen","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib414","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1620\/tjem.143.335","article-title":"Influence of vagotomy upon GIP release in patients with peptic ulcer","volume":"143","author":"Imamura","year":"1984","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.molmet.2025.102118_bib415","first-page":"397","article-title":"Effect of truncal, selective, and highly selective vagotomy on fat-induced gastric inhibitory polypeptide release","volume":"29","author":"Gayle","year":"1978","journal-title":"Surg Forum"},{"key":"10.1016\/j.molmet.2025.102118_bib416","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archsurg.1974.01360020039009","article-title":"Gastric inhibitory polypeptide. Response to oral glucose after vagotomy and pyloroplasty","volume":"109","author":"Thomford","year":"1974","journal-title":"Arch Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib417","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF01536919","article-title":"Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs","volume":"35","author":"Kogire","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib418","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/00365528209182054","article-title":"Beta-adrenergic stimulation and blockade of the release of gastric inhibitory polypeptide and insulin in man","volume":"17","author":"Flaten","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib419","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/BF01391372","article-title":"Adrenergic modulation of gastric inhibitory polypeptide secretion in man","volume":"27","author":"Salera","year":"1982","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib420","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.peptides.2008.08.024","article-title":"Intracerebroventricular infusion of neuropeptide Y increases glucose dependent-insulinotropic peptide secretion in the fasting conscious dog","volume":"29","author":"Yavropoulou","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib421","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.peptides.2009.09.029","article-title":"Effect of intracerebroventricular infusion of neurotensin in glucose-dependent\u00a0insulinotropic peptide secretion in dogs","volume":"31","author":"Yavropoulou","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib422","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/db11-0979","article-title":"Glucose-dependent\u00a0insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans","volume":"60","author":"Christensen","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib423","first-page":"E185","article-title":"Pancreatic alpha- and beta-cell responses to GIP infusion in normal man","volume":"237","author":"Elahi","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib424","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI109765","article-title":"Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function","volume":"65","author":"Verdonk","year":"1980","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib425","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1177\/002215540004801205","article-title":"Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals","volume":"48","author":"Anlauf","year":"2000","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.molmet.2025.102118_bib426","first-page":"889","article-title":"Identification of proxenin as a precursor of the peptide xenin with sequence homology to yeast and mammalian coat protein alpha","volume":"17","author":"Hamscher","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib427","doi-asserted-by":"crossref","first-page":"22305","DOI":"10.1016\/S0021-9258(18)41670-5","article-title":"Identification of xenin, a xenopsin-related peptide, in the human gastric mucosa and its effect on exocrine pancreatic secretion","volume":"267","author":"Feurle","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib428","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1399-3011.1997.tb01132.x","article-title":"Gastroenteropancreatic effects of xenin in the dog","volume":"49","author":"Feurle","year":"1997","journal-title":"J\u00a0Pept Res"},{"key":"10.1016\/j.molmet.2025.102118_bib429","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0006-8993(98)00535-6","article-title":"Xenin--a novel suppressor of food intake in rats","volume":"800","author":"Alexiou","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.molmet.2025.102118_bib430","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.npep.2017.01.007","article-title":"Central action of xenin affects the expression of lipid metabolism-related genes and proteins in mouse white adipose tissue","volume":"63","author":"Bhavya","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.molmet.2025.102118_bib431","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/oby.2008.652","article-title":"Peripheral and central administration of xenin and neurotensin suppress food intake in rodents","volume":"17","author":"Cooke","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.molmet.2025.102118_bib432","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2337\/db08-0260","article-title":"Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway","volume":"58","author":"Leckstrom","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib433","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/JOE-10-0085","article-title":"Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety","volume":"207","author":"Taylor","year":"2010","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib434","doi-asserted-by":"crossref","first-page":"G301","DOI":"10.1152\/ajpgi.00383.2013","article-title":"Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes","volume":"306","author":"Chowdhury","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib435","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2010.06.055","article-title":"Xenin delays gastric emptying rate and activates the brainstem in mice","volume":"481","author":"Kim","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.molmet.2025.102118_bib436","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2012.04.015","article-title":"Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25","volume":"84","author":"Martin","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib437","doi-asserted-by":"crossref","first-page":"19842","DOI":"10.1074\/jbc.M110.129304","article-title":"Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism","volume":"285","author":"Wice","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib438","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2337\/db11-1451","article-title":"Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes","volume":"61","author":"Wice","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib439","doi-asserted-by":"crossref","first-page":"18365","DOI":"10.1074\/jbc.M710466200","article-title":"Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet","volume":"283","author":"Althage","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib440","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00125-016-4186-y","article-title":"An enzymatically stable GIP\/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice","volume":"60","author":"Hasib","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib441","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3384","article-title":"Enzymatically stable analogue of the gut-derived peptide xenin on beta-cell transdifferentiation in high fat fed and insulin-deficient Ins1(Cre\/+) ;Rosa26-eYFP mice","volume":"37","author":"Tanday","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.molmet.2025.102118_bib442","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3181\/00379727-182-42377","article-title":"Effect of bombesin and gastrin-releasing peptide on the release of gastric inhibitory polypeptide and insulin in rats","volume":"182","author":"Greeley","year":"1986","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.molmet.2025.102118_bib443","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0196-9781(94)90101-5","article-title":"Bombesin receptor subtype mediation of gastroenteropancreatic hormone secretion in rats","volume":"15","author":"Varga","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib444","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0167-0115(81)90034-3","article-title":"A\u00a0qualitative comparison of canine plasma gastroenteropancreatic hormone response to bombesin and the porcine gastrin-releasing peptide (GRP)","volume":"2","author":"McDonald","year":"1981","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib445","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1210\/jcem-59-2-310","article-title":"Gastrin-releasing peptide: pharmacokinetics and effects on gastro-entero-pancreatic hormones and gastric secretion in normal men","volume":"59","author":"Knigge","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib446","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2003.08.042","article-title":"Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion","volume":"481","author":"Konturek","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib447","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/cs0650365","article-title":"The effect of the mammalian neuropeptide, gastrin-releasing peptide (GRP), on gastrointestinal and pancreatic hormone secretion in man","volume":"65","author":"Wood","year":"1983","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.molmet.2025.102118_bib448","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/JOE-15-0247","article-title":"GLP1- and GIP-producing cells rarely overlap and differ by bombesin receptor-2 expression and responsiveness","volume":"228","author":"Svendsen","year":"2016","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib449","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/187152706776359673","article-title":"Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders","volume":"5","author":"Roesler","year":"2006","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.molmet.2025.102118_bib450","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0016-5085(87)90257-5","article-title":"Localization of specific binding sites for bombesin in the canine gastrointestinal tract","volume":"93","author":"Vigna","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib451","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1749-6632.1996.tb15126.x","article-title":"Bombesin receptors in the brain","volume":"780","author":"Woodruff","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib452","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1113\/jphysiol.1990.sp018133","article-title":"Substance P and bombesin elevate cytosolic Ca2+ by different molecular\u00a0mechanisms in a rat pancreatic acinar cell line","volume":"426","author":"Gallacher","year":"1990","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib453","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-0115(83)90278-1","article-title":"Release of bombesin-like immunoreactivity from the isolated perfused rat stomach","volume":"7","author":"Schusdziarra","year":"1983","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib454","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1139\/y81-069","article-title":"Gastric inhibitory polypeptide stimulated secretion of somatostatinlike immunoreactivity from the stomach: inhibition by acetylcholine or vagal stimulation","volume":"59","author":"McIntosh","year":"1981","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib455","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1210\/en.2015-1301","article-title":"A\u00a0transcriptome-led exploration of molecular mechanisms regulating somatostatin-producing D-cells in the gastric epithelium","volume":"156","author":"Adriaenssens","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib456","first-page":"45","article-title":"Inhibition of somatostatin on glucose-induced release of gastric inhibitory polypeptide in rats","volume":"30","author":"Ho","year":"1987","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib457","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/joe.0.1510107","article-title":"Effects of somatostatin-28 on circulating concentrations of insulin and gut hormones in sheep","volume":"151","author":"Martin","year":"1996","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib458","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000198787","article-title":"Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man","volume":"24","author":"Salera","year":"1982","journal-title":"Digestion"},{"key":"10.1016\/j.molmet.2025.102118_bib459","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1139\/y75-168","article-title":"The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide","volume":"53","author":"Pederson","year":"1975","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib460","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1172\/JCI114246","article-title":"A\u00a0physiologic role for somatostatin 28 as a regulator of insulin secretion","volume":"84","author":"D'Alessio","year":"1989","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib461","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/291076a0","article-title":"Selective effects of somatostatin-14, -25 and -28 on in\u00a0vitro insulin and glucagon secretion","volume":"291","author":"Mandarino","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib462","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(74)90869-1","article-title":"Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone","volume":"2","author":"Bloom","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib463","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(79)90131-6","article-title":"Kinetics of somatostatin inhibition of pentagastrin-stimualted gastric acid secretion","volume":"53","author":"Barbezat","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib464","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102118_bib465","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0167-0115(85)90057-6","article-title":"The intestinal mucosa preferentially releases somatostatin-28 in pigs","volume":"11","author":"Baldissera","year":"1985","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib466","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2340\/0001555558467469","article-title":"Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans","volume":"58","author":"Olsson","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.molmet.2025.102118_bib467","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s004419900093","article-title":"Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine","volume":"298","author":"Damholt","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.molmet.2025.102118_bib468","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1139\/y83-102","article-title":"Enkephalinergic control of somatostatin secretion from the perfused rat stomach","volume":"61","author":"McIntosh","year":"1983","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib469","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(94)90663-7","article-title":"Beta-funaltrexamine blockade of opioid-induced inhibition of somatostatin secretion from rat stomach","volume":"259","author":"McIntosh","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib470","first-page":"G922","article-title":"Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion","volume":"259","author":"McIntosh","year":"1990","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.molmet.2025.102118_bib471","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00125-024-06293-3","article-title":"Molecular mechanisms underlying glucose-dependent insulinotropic polypeptide secretion in human duodenal organoids","volume":"68","author":"Guccio","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib472","first-page":"351","article-title":"Gastric inhibitory polypeptide and the entero-insular axis in streptozotocin diabetic mice","volume":"12","author":"Bailey","year":"1986","journal-title":"Diabete Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib473","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00280527","article-title":"Endocrine pancreatic control of the release of gastric inhibitory polypeptide. A possible physiological role for C-peptide","volume":"19","author":"Dryburgh","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib474","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1677\/joe.0.1720355","article-title":"Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs","volume":"172","author":"Deacon","year":"2002","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib475","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-13-0487","article-title":"Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT","volume":"169","author":"Alssema","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib476","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1210\/jc.2013-3994","article-title":"GIP contributes to islet trihormonal abnormalities in type 2 diabetes","volume":"99","author":"Chia","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib477","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00429703","article-title":"Gastric inhibitory\u00a0polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels","volume":"14","author":"Creutzfeldt","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib478","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diab.25.10.931","article-title":"Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus","volume":"25","author":"Crockett","year":"1976","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib479","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/BF00274255","article-title":"The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus","volume":"32","author":"Jones","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib480","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2337\/diab.26.6.525","article-title":"Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus","volume":"26","author":"Ross","year":"1977","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib481","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem-55-2-329","article-title":"Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity","volume":"55","author":"Salera","year":"1982","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib482","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2010.01.134","article-title":"Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes","volume":"393","author":"Kozawa","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib483","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1464-5491.1992.tb01835.x","article-title":"Gastric inhibitory polypeptide (GIP) response in diabetes using a highly specific antiserum","volume":"9","author":"Alam","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/j.molmet.2025.102118_bib484","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1152\/ajpendo.00326.2004","article-title":"Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP","volume":"290","author":"Theodorakis","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib485","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jcem.86.8.7750","article-title":"Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients","volume":"86","author":"Toft-Nielsen","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib486","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF01220638","article-title":"Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency","volume":"12","author":"Ebert","year":"1976","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib487","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1515\/BC.2011.176","article-title":"Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats","volume":"392","author":"Irwin","year":"2011","journal-title":"Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib488","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2337\/diabetes.51.4.951","article-title":"Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose","volume":"51","author":"Greenbaum","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib489","first-page":"74","article-title":"Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabetics","volume":"114","author":"Krarup","year":"1987","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib490","first-page":"364","article-title":"The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics","volume":"11","author":"Krarup","year":"1985","journal-title":"Diabete Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib491","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2478\/folmed-2018-0056","article-title":"Serum levels of incretin hormones - GLP-1 and GIP in patients with type 1 diabetes mellitus","volume":"61","author":"Stanchev","year":"2019","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.molmet.2025.102118_bib492","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1210\/jcem-58-6-1133","article-title":"Gastric inhibitory polypeptide in obesity and diabetes mellitus","volume":"58","author":"Service","year":"1984","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib493","doi-asserted-by":"crossref","first-page":"647","DOI":"10.33549\/physiolres.931995","article-title":"Gut peptide hormones and pediatric type 1 diabetes mellitus","volume":"60","author":"Huml","year":"2011","journal-title":"Physiol Res"},{"key":"10.1016\/j.molmet.2025.102118_bib494","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1210\/jcem-60-1-120","article-title":"Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus","volume":"60","author":"Krarup","year":"1985","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib495","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/ENDO:16:3:167","article-title":"Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob\/ob) mice","volume":"16","author":"Mooney","year":"2001","journal-title":"Endocrine"},{"key":"10.1016\/j.molmet.2025.102118_bib496","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jc.2015-3133","article-title":"Glucose-dependent insulinotropic polypeptide is associated with lower low-density lipoprotein but unhealthy fat distribution, independent of insulin: the ADDITION-PRO study","volume":"101","author":"Moller","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib497","first-page":"E767","article-title":"Role of gastric inhibitory polypeptide in postprandial hyperinsulinemia of obesity","volume":"254","author":"Roust","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib498","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02581191","article-title":"Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia","volume":"26","author":"Ebert","year":"1989","journal-title":"Acta Diabetol Lat"},{"key":"10.1016\/j.molmet.2025.102118_bib499","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1203\/00006450-198004000-00008","article-title":"Effects of diet on insulin and gastric inhibitory polypeptide levels in obese children","volume":"14","author":"Deschamps","year":"1980","journal-title":"Pediatr Res"},{"key":"10.1016\/j.molmet.2025.102118_bib500","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/diab.33.10.950","article-title":"The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus","volume":"33","author":"Elahi","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib501","first-page":"649","article-title":"Similar plasma GIP responses in obese and lean subjects after an oral test meal and after intraduodenal stimulation with fat and glucose","volume":"8","author":"Amland","year":"1984","journal-title":"Int J Obes"},{"key":"10.1016\/j.molmet.2025.102118_bib502","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/00365528009181506","article-title":"Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass","volume":"15","author":"Lauritsen","year":"1980","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib503","first-page":"155P","article-title":"Radioimmunoassay of gastric inhibitory polypeptide and its release in morbid obesity and after jejuno-ileal bypass [proceedings]","volume":"81","author":"Sarson","year":"1979","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib504","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF00282515","article-title":"Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man","volume":"25","author":"Sarson","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib505","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/dom.13934","article-title":"Persistent whole day meal effects of three dipeptidyl peptidase-4 inhibitors on glycaemia and hormonal responses in metformin-treated type 2 diabetes","volume":"22","author":"Alsalim","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib506","series-title":"Current approaches: obesity W. P. T. James and S. W. Parker","first-page":"13","article-title":"Gip - the obesity hormone","author":"Marks","year":"1988"},{"key":"10.1016\/j.molmet.2025.102118_bib507","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00125-009-1288-9","article-title":"Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion","volume":"52","author":"Mingrone","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib508","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2337\/dc08-1314","article-title":"First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery","volume":"32","author":"Salinari","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib509","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1381\/096089298765554449","article-title":"Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity","volume":"8","author":"Naslund","year":"1998","journal-title":"Obes Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib510","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1262-3636(09)73458-5","article-title":"Effect of gastric bypass surgery on the incretins","volume":"35","author":"Laferrere","year":"2009","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib511","first-page":"235","article-title":"Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass","volume":"92","author":"Halverson","year":"1982","journal-title":"Surgery"},{"key":"10.1016\/j.molmet.2025.102118_bib512","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s11695-012-0621-4","article-title":"Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects","volume":"22","author":"Jacobsen","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib513","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1152\/ajpendo.00073.2012","article-title":"Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance","volume":"303","author":"Jorgensen","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib514","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2337\/db22-0568","article-title":"The importance of endogenously secreted GLP-1 and GIP for postprandial glucose tolerance and beta-cell function after roux-en-Y gastric bypass and sleeve gastrectomy surgery","volume":"72","author":"Hindso","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib515","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.asjsur.2013.09.008","article-title":"Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients","volume":"37","author":"Kim","year":"2014","journal-title":"Asian J Surg"},{"key":"10.1016\/j.molmet.2025.102118_bib516","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2004-1076","article-title":"Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin","volume":"90","author":"Korner","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib517","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.soard.2007.08.004","article-title":"Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding","volume":"3","author":"Korner","year":"2007","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.molmet.2025.102118_bib518","first-page":"471","article-title":"Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity","volume":"5","author":"Sarson","year":"1981","journal-title":"Int J Obes"},{"key":"10.1016\/j.molmet.2025.102118_bib519","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/jdi.12005","article-title":"Changes of blood glucose and gastrointestinal hormones 4 months after Roux-en-Y gastric bypass surgery in Chinese obese type 2 diabetes patients with lower body mass index","volume":"4","author":"Wu","year":"2013","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286062","article-title":"RYGB surgery has modest effects on intestinal morphology and gut hormone populations in the bypassed biliopancreatic limb but causes reciprocal changes in GLP-2 and PYY in the alimentary limb","volume":"18","author":"Sridhar","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib521","doi-asserted-by":"crossref","first-page":"E324","DOI":"10.1152\/ajpendo.00059.2006","article-title":"Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution","volume":"292","author":"Knop","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib522","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1210\/jc.2013-4417","article-title":"Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial","volume":"99","author":"Perano","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib523","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2337\/db22-0399","article-title":"Effects of GLP-1 and GIP on islet function in glucose-intolerant, pancreatic-insufficient cystic fibrosis","volume":"71","author":"Nyirjesy","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib524","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0026-0495(84)90188-4","article-title":"Gastroenteropancreatic hormones in normal and gestational-diabetic pregnancy: response to oral lipid","volume":"33","author":"Hornnes","year":"1984","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib525","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diab.30.6.504","article-title":"Gastrointestinal insulinotropic hormones in normal and gestational-diabetic pregnancy: response to oral glucose","volume":"30","author":"Hornnes","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib526","doi-asserted-by":"crossref","first-page":"e2425","DOI":"10.1210\/clinem\/dgac095","article-title":"Incretin hypersecretion in gestational diabetes mellitus","volume":"107","author":"Fritsche","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib527","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/dom.12082","article-title":"Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus","volume":"15","author":"Bonde","year":"2013","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib528","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00125-005-1863-7","article-title":"Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes","volume":"48","author":"Meier","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib529","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078560","article-title":"Alterations of glucose-dependent insulinotropic polypeptide and expression of genes involved in mammary gland and adipose tissue lipid metabolism during pregnancy and lactation","volume":"8","author":"Moffett","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib530","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.regpep.2010.12.001","article-title":"Alterations of glucose-dependent insulinotropic polypeptide (GIP) during cold acclimation","volume":"167","author":"Irwin","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib531","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib532","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome","volume":"327","author":"Lacroix","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib533","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide","volume":"327","author":"Reznik","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib534","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.diabres.2010.01.006","article-title":"A\u00a0case of insulinoma following total gastrectomy--effects of an alpha-glucosidase inhibitor on suppressing GIP and GLP-1 elevations","volume":"88","author":"Sato","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.molmet.2025.102118_bib535","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diab.36.11.1336","article-title":"Evidence of functional gastric inhibitory polypeptide (GIP) receptors in human insulinoma. Binding of synthetic human GIP 1-31 and activation of adenylate cyclase","volume":"36","author":"Maletti","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib536","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/jc.2011-2454","article-title":"Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors","volume":"97","author":"Waser","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib537","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/EJE-16-0831","article-title":"The GIP\/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp(-) somatotropinomas","volume":"176","author":"Regazzo","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib538","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010061","article-title":"Imaging of the glucose-dependent insulinotropic polypeptide receptor using a novel radiolabeled peptide rationally designed based on endogenous GIP and synthetic exendin-4 sequences","volume":"16","author":"Velikyan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.molmet.2025.102118_bib539","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/bjc.1987.224","article-title":"Defective regulation of insulin release and transmembrane Ca2+ fluxes by human islet cell tumours","volume":"56","author":"Flatt","year":"1987","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2025.102118_bib540","first-page":"200","article-title":"Glucose-induced GIP levels in patients with insulinoma","volume":"16","author":"Tamburrano","year":"1984","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.molmet.2025.102118_bib541","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/endo.133.6.8243312","article-title":"Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain","volume":"133","author":"Usdin","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib542","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/diab.44.10.1202","article-title":"Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor","volume":"44","author":"Gremlich","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib543","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-5793(95)01006-Z","article-title":"Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma","volume":"373","author":"Volz","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.molmet.2025.102118_bib544","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/pr.55.1.6","article-title":"International Union of Pharmacology. XXXV. The glucagon receptor family","volume":"55","author":"Mayo","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.molmet.2025.102118_bib545","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1677\/jme.0.0100259","article-title":"Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells","volume":"10","author":"Gallwitz","year":"1993","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib546","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1073\/pnas.89.18.8641","article-title":"Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1","volume":"89","author":"Thorens","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib547","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.peptides.2017.11.007","article-title":"Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: evidence for involvement of the GLP-1 receptor","volume":"100","author":"Graham","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib548","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101181","article-title":"Spatiotemporal GLP-1 and GIP receptor signaling and trafficking\/recycling dynamics induced by selected receptor mono- and dual-agonists","volume":"49","author":"Novikoff","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib549","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102118_bib550","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126742","article-title":"Beta Cell tone is defined by proglucagon peptides through cAMP signaling","volume":"4","author":"Capozzi","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102118_bib551","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1074\/jbc.AAC119.009193","article-title":"Correction: nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP","volume":"294","author":"Chepurny","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib552","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","article-title":"Insulin secretion depends on intra-islet glucagon signaling","volume":"25","author":"Svendsen","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib553","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1172\/JCI140046","article-title":"Gs\/Gq signaling switch in beta cells defines incretin effectiveness in diabetes","volume":"130","author":"Oduori","year":"2020","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib554","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad028","article-title":"Enhanced endosomal signaling and desensitization of GLP-1R vs GIPR in pancreatic beta cells","volume":"164","author":"Manchanda","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib555","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016334","article-title":"Genetic and biased agonist-mediated reductions in beta-arrestin recruitment prolong cAMP signaling at glucagon family receptors","volume":"296","author":"Jones","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib556","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119584","article-title":"Characterization of the real-time internalization of nine GPCRs reveals distinct dependence on arrestins and G proteins","volume":"1871","author":"Moller","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.molmet.2025.102118_bib557","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1016\/j.celrep.2016.11.050","article-title":"Downregulation of a GPCR by beta-arrestin2-mediated switch from an endosomal to a TGN recycling pathway","volume":"17","author":"Abdullah","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib558","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41467-018-03941-2","article-title":"Targeting GLP-1 receptor trafficking to improve agonist efficacy","volume":"9","author":"Jones","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib559","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2018.01.040","article-title":"Human GIP(3-30)NH(2) inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors","volume":"150","author":"Gabe","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib560","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s42255-024-01061-4","article-title":"Characterization of genetic variants of GIPR reveals a contribution of beta-arrestin to metabolic phenotypes","volume":"6","author":"Kizilkaya","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib561","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf7737","article-title":"Divergent acute versus prolonged pharmacological GLP-1R responses in adult beta cell-specific beta-arrestin 2 knockout mice","volume":"9","author":"Bitsi","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.molmet.2025.102118_bib562","doi-asserted-by":"crossref","DOI":"10.1111\/bph.16478","article-title":"Altered desensitization and internalization patterns of rodent versus human glucose-dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge","author":"Gasbjerg","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib563","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fphar.2020.01271","article-title":"The effect of cell surface expression and linker sequence on the recruitment of arrestin to the GIP receptor","volume":"11","author":"Al-Sabah","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib564","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bph.13323","article-title":"Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors","volume":"173","author":"Sparre-Ulrich","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib565","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0083-6729(08)00615-8","article-title":"Glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide; GIP)","volume":"80","author":"McIntosh","year":"2009","journal-title":"Vitam Horm"},{"key":"10.1016\/j.molmet.2025.102118_bib566","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.0706404104","article-title":"Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor","volume":"104","author":"Parthier","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib567","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114715","article-title":"Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor","volume":"192","author":"Yuliantie","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib568","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/mol.109.060111","article-title":"Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand","volume":"77","author":"Yaqub","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib569","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68719","article-title":"Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor","volume":"10","author":"Zhao","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.molmet.2025.102118_bib570","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.str.2021.04.001","article-title":"Investigating GIPR (ant)agonism: a structural analysis of GIP and its receptor","volume":"29","author":"Smit","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.molmet.2025.102118_bib571","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1748-1716.1986.tb07911.x","article-title":"Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP(1-39)","volume":"127","author":"Sandberg","year":"1986","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.molmet.2025.102118_bib572","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/endo.136.10.7664683","article-title":"Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties","volume":"136","author":"Wheeler","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib573","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/BC.2003.046","article-title":"Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP)","volume":"384","author":"Hinke","year":"2003","journal-title":"Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib574","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/bph.13384","article-title":"N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor","volume":"173","author":"Hansen","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib575","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-0115(97)00009-8","article-title":"GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in\u00a0vitro","volume":"69","author":"Gelling","year":"1997","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib576","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419875453","article-title":"Characterisation of glucose-dependent insulinotropic polypeptide receptor antagonists in rodent pancreatic beta cells and mice","volume":"12","author":"Perry","year":"2019","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib577","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbrc.2010.12.077","article-title":"Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide","volume":"404","author":"Kerr","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib578","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00125-017-4447-4","article-title":"GIP(3-30)NH(2) is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study","volume":"61","author":"Gasbjerg","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib579","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103739","article-title":"Reagents and models for detecting endogenous GLP1R and GIPR","volume":"74","author":"Ast","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.molmet.2025.102118_bib580","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164921","article-title":"Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding","volume":"8","author":"Adriaenssens","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102118_bib581","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s42255-023-00931-7","article-title":"Glucose-dependent insulinotropic polypeptide regulates body weight\u00a0and food intake via GABAergic neurons in mice","volume":"5","author":"Liskiewicz","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib582","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1432-1033.1986.tb09875.x","article-title":"Gastric inhibitory polypeptide receptor in hamster pancreatic beta cells. Direct cross-linking, solubilization and characterization as a glycoprotein","volume":"159","author":"Amiranoff","year":"1986","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib583","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1210\/endo-115-4-1324","article-title":"Evidence for and characterization of specific high affinity binding sites for the gastric inhibitory polypeptide in pancreatic beta-cells","volume":"115","author":"Maletti","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib584","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/jme.1.01765","article-title":"The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome","volume":"35","author":"Baldacchino","year":"2005","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib585","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","article-title":"Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors","volume":"141","author":"Bollag","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib586","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(94)90016-7","article-title":"Gastric inhibitory polypeptide (GIP) binding sites in rat brain","volume":"15","author":"Kaplan","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib587","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","article-title":"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake","volume":"30","author":"Adriaenssens","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib588","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121736","article-title":"Evidence for involvement of GIP and GLP-1 receptors and the gut-gonadal Axis in regulating female reproductive function in mice","volume":"12","author":"Khan","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmet.2025.102118_bib589","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/db21-1166","article-title":"GIPR is predominantly localized to nonadipocyte cell types within white adipose tissue","volume":"71","author":"Campbell","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib590","doi-asserted-by":"crossref","DOI":"10.1242\/dev.173716","article-title":"A\u00a0transcriptomic roadmap to alpha- and beta-cell differentiation in the embryonic pancreas","volume":"146","author":"van Gurp","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.molmet.2025.102118_bib591","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101915","article-title":"Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice","author":"Akindehin","year":"2024","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib592","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-020-18751-8","article-title":"Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism","volume":"11","author":"Killion","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib593","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41586-022-04518-2","article-title":"A\u00a0single-cell atlas of human and mouse white adipose tissue","volume":"603","author":"Emont","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib594","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1053\/j.gastro.2007.09.005","article-title":"Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation","volume":"133","author":"Song","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib595","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/ijo.2008.148","article-title":"Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model","volume":"32","author":"Weaver","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.molmet.2025.102118_bib596","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1194\/jlr.M012203","article-title":"Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARgamma and histone acetylation","volume":"52","author":"Kim","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.molmet.2025.102118_bib597","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/endo.140.1.6464","article-title":"Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin","volume":"140","author":"McIntosh","year":"1999","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.molmet.2025.102118_bib598","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","article-title":"Tirzepatide\u00a0modulates the regulation of adipocyte nutrient metabolism\u00a0through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib599","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2337\/diab.28.12.1141","article-title":"Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes","volume":"28","author":"Eckel","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib600","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1074\/jbc.M609088200","article-title":"Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade","volume":"282","author":"Kim","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib601","doi-asserted-by":"crossref","first-page":"34139","DOI":"10.1074\/jbc.M704896200","article-title":"Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes","volume":"282","author":"Kim","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib602","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1194\/jlr.M006841","article-title":"GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene","volume":"51","author":"Kim","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.molmet.2025.102118_bib603","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","article-title":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib604","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000177467","article-title":"Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes","volume":"32","author":"Hauner","year":"1988","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib605","first-page":"E603","article-title":"GIP increases insulin receptor affinity and cellular sensitivity in adipocytes","volume":"249","author":"Starich","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib606","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/187152411798047771","article-title":"Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival","volume":"11","author":"Paratore","year":"2011","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib607","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","article-title":"A\u00a0genetic map of the mouse dorsal vagal complex and its role in obesity","volume":"3","author":"Ludwig","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib608","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s42255-022-00657-y","article-title":"HypoMap-a unified single-cell gene expression atlas of the murine hypothalamus","volume":"4","author":"Steuernagel","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib609","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2022.106022","article-title":"A\u00a0comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus","volume":"174","author":"Smith","year":"2022","journal-title":"Appetite"},{"key":"10.1016\/j.molmet.2025.102118_bib610","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101240","article-title":"A\u00a0survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing","volume":"53","author":"Dowsett","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib611","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","article-title":"Area postrema cell types that mediate nausea-associated behaviors","volume":"109","author":"Zhang","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.molmet.2025.102118_bib612","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2337\/db17-1385","article-title":"Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons","volume":"67","author":"Adams","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib613","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2337\/db09-1655","volume":"59","author":"Gupta","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib614","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.2040-1124.2012.00196.x","article-title":"Glucose-dependent insulinotropic polypeptide signaling in pancreatic beta-cells and adipocytes","volume":"3","author":"McIntosh","year":"2012","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib615","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/db23-0172","article-title":"GIPR agonism enhances TZD-induced insulin sensitivity in obese IR mice","volume":"73","author":"Furber","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib616","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1210\/endo-128-6-2880","article-title":"Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor on insulinoma (HIT-T15) cells","volume":"128","author":"Fehmann","year":"1991","journal-title":"Endocrinology"},{"issue":"Suppl 3","key":"10.1016\/j.molmet.2025.102118_bib617","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.2337\/diabetes.53.suppl_3.S205","article-title":"Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in\u00a0vitro but does not attenuate GLP-1R-dependent glucose homeostasis in\u00a0vivo","volume":"53","author":"Baggio","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib618","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-5793(89)80899-3","article-title":"Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas","volume":"252","author":"Fehmann","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.molmet.2025.102118_bib619","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0026-0495(92)90068-L","article-title":"Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas","volume":"41","author":"Suzuki","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib620","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.regpep.2004.07.019","article-title":"GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice","volume":"128","author":"Hansotia","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib621","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1172\/JCI200420518","article-title":"Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors","volume":"113","author":"Preitner","year":"2004","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib622","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1074\/jbc.270.15.8971","article-title":"Differences in glucose transporter gene expression between rat pancreatic alpha- and beta-cells are correlated to differences in glucose transport but not in glucose utilization","volume":"270","author":"Heimberg","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib623","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1172\/JCI118308","article-title":"Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression","volume":"96","author":"De Vos","year":"1995","journal-title":"J\u00a0Clin Investig"},{"issue":"8","key":"10.1016\/j.molmet.2025.102118_bib624","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/db23-0508","article-title":"Glucose transporters are key components of the human glucostat","volume":"73","author":"Caspi","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib625","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/diab.21.2.S538","article-title":"Insulin secretion mechanisms and glucose metabolism in isolated islets","volume":"21","author":"Ashcroft","year":"1972","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib626","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/dbi22-0030","article-title":"KATP channels and the metabolic regulation of insulin secretion in health and disease: the 2022 Banting Medal for Scientific Achievement Award Lecture","volume":"72","author":"Ashcroft","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib627","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1073\/pnas.95.12.7185","article-title":"MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit","volume":"95","author":"Gribble","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib628","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.2337\/diabetes.51.12.3440","article-title":"cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets","volume":"51","author":"Nakazaki","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib629","doi-asserted-by":"crossref","first-page":"37176","DOI":"10.1074\/jbc.M206757200","article-title":"Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose","volume":"277","author":"Shiota","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib630","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/361362a0","article-title":"Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)","volume":"361","author":"Holz","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib631","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s004240050431","article-title":"Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors","volume":"434","author":"Gromada","year":"1997","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.molmet.2025.102118_bib632","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1210\/endo.132.1.8380389","article-title":"The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37)","volume":"132","author":"Lu","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib633","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0303-7207(92)90109-J","article-title":"Are ionic fluxes of pancreatic beta cells a target for gastric inhibitory polypeptide?","volume":"90","author":"Wahl","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib634","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diab.47.1.57","article-title":"Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling","volume":"47","author":"Gromada","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib635","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1210\/endo.133.4.8404610","article-title":"Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity","volume":"133","author":"Yada","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib636","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/BF00291078","article-title":"Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content","volume":"28","author":"Siegel","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib637","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0006-291X(84)90281-X","article-title":"Functional GIP receptors in a hamster pancreatic beta cell line, in 111: specific binding and biological effects","volume":"123","author":"Amiranoff","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib638","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF00501444","article-title":"Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats","volume":"326","author":"Ammon","year":"1984","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib639","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/BF00870283","article-title":"Insulin secretory responses of a clonal cell line of simian virus 40-transformed B cells","volume":"29","author":"Ashcroft","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib640","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01122227","article-title":"Inhibitory\u00a0effect of clonidine upon adenylate cyclase activity, cyclic AMP production, and insulin release in rat pancreatic islets","volume":"4","author":"Garcia-Morales","year":"1984","journal-title":"Biosci Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib641","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/endo-115-5-2015","article-title":"Forskolin-induced activation of adenylate cyclase, cyclic adenosine monophosphate production and insulin release in rat pancreatic islets","volume":"115","author":"Malaisse","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib642","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1210\/endo-113-6-2311","article-title":"Effects of forskolin on insulin release and cyclic AMP content in rat pancreatic islets","volume":"113","author":"Wiedenkeller","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib643","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/diab.34.2.115","article-title":"Perifusion of a clonal cell line of Simian virus 40-transformed beta cells. Insulin secretory dynamics in response to glucose, 3-isobutyl-1-methylxanthine, and potassium","volume":"34","author":"Hill","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib644","doi-asserted-by":"crossref","first-page":"37446","DOI":"10.1074\/jbc.M205401200","article-title":"Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin","volume":"277","author":"Harndahl","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib645","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1074\/jbc.M308952200","article-title":"Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology","volume":"279","author":"Harndahl","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib646","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.1021\/bi00099a032","article-title":"Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I","volume":"30","author":"Dostmann","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmet.2025.102118_bib647","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1146\/annurev.bi.59.070190.004543","article-title":"cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes","volume":"59","author":"Taylor","year":"1990","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib648","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1016\/S0021-9258(19)44739-X","article-title":"Characterization of the interaction of a protein inhibitor with adenosine 3',5'-monophosphate-dependent protein kinases. I. Interaction with the catalytic subunit of the protein kinase","volume":"247","author":"Ashby","year":"1972","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib649","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1073\/pnas.71.9.3580","article-title":"Activation of protein kinase by physiological concentrations of cyclic AMP","volume":"71","author":"Beavo","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib650","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/emboj\/18.17.4722","article-title":"PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation","volume":"18","author":"Beguin","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.molmet.2025.102118_bib651","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1085\/jgp.94.4.693","article-title":"ATP mediates both activation and inhibition of K(ATP) channel activity via cAMP-dependent protein kinase in insulin-secreting cell lines","volume":"94","author":"Ribalet","year":"1989","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib652","doi-asserted-by":"crossref","first-page":"33851","DOI":"10.1074\/jbc.274.48.33851","article-title":"Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the beta(2) subunit","volume":"274","author":"Bunemann","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib653","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1021\/bi953023c","article-title":"Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3',5'-cyclic monophosphate-dependent protein kinase","volume":"35","author":"De Jongh","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmet.2025.102118_bib654","doi-asserted-by":"crossref","first-page":"19401","DOI":"10.1074\/jbc.272.31.19401","article-title":"Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes","volume":"272","author":"Gao","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib655","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2337\/diab.45.10.1412","article-title":"cAMP-dependent phosphorylation of the cardiac-type alpha 1 subunit of the voltage-dependent Ca2+ channel in a murine pancreatic beta-cell line","volume":"45","author":"Leiser","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib656","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/mend.11.5.9922","article-title":"L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells","volume":"11","author":"Safayhi","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib657","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/363356a0","article-title":"Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells","volume":"363","author":"Ammala","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib658","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s004240050556","article-title":"Intracellular cAMP potentiates voltage-dependent activation of L-type Ca2+ channels in rat islet beta-cells","volume":"435","author":"Kanno","year":"1998","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.molmet.2025.102118_bib659","doi-asserted-by":"crossref","first-page":"52446","DOI":"10.1074\/jbc.M307612200","article-title":"Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP\/protein kinase A and phosphatidylinositol 3-kinase signaling pathways","volume":"278","author":"MacDonald","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib660","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1210\/endo.142.5.8128","article-title":"Glucagon-like peptide-1 causes\u00a0pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate\/protein kinase A-dependent mechanism","volume":"142","author":"Wang","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib661","doi-asserted-by":"crossref","first-page":"E1001","DOI":"10.1152\/ajpendo.00005.2003","article-title":"Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells","volume":"285","author":"Miura","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib662","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1210\/endo.137.11.8895328","article-title":"Ca2+\/calmodulin and cyclic 3,5' adenosine monophosphate control movement of secretory granules through protein phosphorylation\/dephosphorylation in the pancreatic beta-cell","volume":"137","author":"Hisatomi","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib663","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1742-7843.2004.t01-1-pto950502.x","article-title":"Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential","volume":"95","author":"Gromada","year":"2004","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"Pt 1","key":"10.1016\/j.molmet.2025.102118_bib664","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1469-7793.1997.105bl.x","article-title":"Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells","volume":"502","author":"Renstrom","year":"1997","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib665","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1042\/bj1290551","article-title":"The mode of action of adenosine 3':5'-cyclic monophosphate in mammalian islets of Langerhans. Preparation and properties of islet-cell protein phosphokinase","volume":"129","author":"Montague","year":"1972","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib666","doi-asserted-by":"crossref","first-page":"E622","DOI":"10.1152\/ajpendo.00630.2009","article-title":"PKA-dependent potentiation of glucose-stimulated insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM in human islets of Langerhans","volume":"298","author":"Chepurny","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib667","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diabetes.53.1.5","article-title":"Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell","volume":"53","author":"Holz","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib668","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1113\/jphysiol.2006.119644","article-title":"Cell physiology of cAMP sensor Epac","volume":"577","author":"Holz","year":"2006","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib669","doi-asserted-by":"crossref","first-page":"46046","DOI":"10.1074\/jbc.M108378200","article-title":"Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion","volume":"276","author":"Kashima","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib670","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.molmet.2025.102118_bib671","doi-asserted-by":"crossref","first-page":"14147","DOI":"10.1074\/jbc.274.20.14147","article-title":"cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37)","volume":"274","author":"Holz","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib672","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1469-7793.2001.0375c.xd","article-title":"cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells","volume":"536","author":"Kang","year":"2001","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib673","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj20021288","article-title":"Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells","volume":"369","author":"Tsuboi","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib674","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2337\/diab.38.3.338","article-title":"Glucagonlike peptide I (7-37) actions on endocrine pancreas","volume":"38","author":"Weir","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib675","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5414\/CPP46273","article-title":"Tolerability, pharmacokinetics and pharmacodynamics of the once-daily human GLP-1 analog liraglutide in Japanese healthy subjects: a randomized, double-blind, placebo-controlled dose-escalation study","volume":"46","author":"Irie","year":"2008","journal-title":"Int J Clin Pharmacol Therapeut"},{"key":"10.1016\/j.molmet.2025.102118_bib676","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diabres.2008.03.018","article-title":"Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: a double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes","volume":"81","author":"Seino","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.molmet.2025.102118_bib677","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/dc06-2593","article-title":"Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes","volume":"30","author":"Vilsboll","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib678","first-page":"35","article-title":"Effectiveness and safety of liraglutide after three years of treatment","volume":"41","author":"Ponzani","year":"2016","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib679","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.EJ14-0602","article-title":"Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight\/obese patients with type 2 diabetes","volume":"62","author":"Tanaka","year":"2015","journal-title":"Endocr J"},{"key":"10.1016\/j.molmet.2025.102118_bib680","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1464-5491.2001.00424.x","article-title":"No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose","volume":"18","author":"Vilsboll","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.molmet.2025.102118_bib681","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jcem.87.3.8355","article-title":"Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers","volume":"87","author":"Nauck","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib682","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2337\/db06-0738","article-title":"Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1","volume":"56","author":"de Heer","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib683","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2337\/diab.46.4.615","article-title":"Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide","volume":"46","author":"Ding","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib684","doi-asserted-by":"crossref","first-page":"50497","DOI":"10.1074\/jbc.M210146200","article-title":"Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis","volume":"277","author":"Fujimoto","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib685","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/35041046","article-title":"cAMP-GEFII is a direct target of cAMP in regulated exocytosis","volume":"2","author":"Ozaki","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib686","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1074\/jbc.M309068200","article-title":"Interaction of ATP sensor, cAMP sensor, Ca2+ sensor, and voltage-dependent Ca2+ channel in insulin granule exocytosis","volume":"279","author":"Shibasaki","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib687","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1172\/JCI81975","article-title":"GLP-1 stimulates insulin secretion by PKC-dependent TRPM4 and TRPM5 activation","volume":"125","author":"Shigeto","year":"2015","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib688","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.1073806","article-title":"Fusion pore dynamics and insulin granule exocytosis in the pancreatic islet","volume":"297","author":"Takahashi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102118_bib689","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1085\/jgp.20028707","article-title":"SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells","volume":"121","author":"Eliasson","year":"2003","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib690","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/endo.130.1.1309325","article-title":"Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells","volume":"130","author":"Fehmann","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib691","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1677\/joe.1.06205","article-title":"Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site","volume":"186","author":"Hay","year":"2005","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib692","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1210\/endo.130.5.1374016","article-title":"Galanin inhibits proinsulin gene expression\u00a0stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells","volume":"130","author":"Fehmann","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib693","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","article-title":"Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells","volume":"268","author":"Goke","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib694","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1210\/endo.136.11.7588224","article-title":"Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells","volume":"136","author":"Wang","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib695","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00125-005-1915-z","article-title":"Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice","volume":"48","author":"Ahren","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib696","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.metabol.2009.10.021","article-title":"Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice","volume":"59","author":"Pacini","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib697","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/diabetes.53.9.2359","article-title":"Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients","volume":"53","author":"Rudovich","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib698","doi-asserted-by":"crossref","first-page":"R639","DOI":"10.1152\/ajpregu.00181.2017","article-title":"Increased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors","volume":"314","author":"Tura","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib699","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1152\/ajpregu.00288.2018","article-title":"Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice","volume":"316","author":"Tura","year":"2019","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib700","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-9343(88)90399-3","article-title":"Hepatic metabolism of insulin","volume":"85","author":"Duckworth","year":"1988","journal-title":"Am J Med"},{"issue":"Pt 2","key":"10.1016\/j.molmet.2025.102118_bib701","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/bj2850563","article-title":"Control of insulin gene expression by glucose","volume":"285","author":"Goodison","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib702","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1210\/endo.140.10.7158","article-title":"Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells","volume":"140","author":"Wang","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib703","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm.3997","article-title":"TCF1 links GIPR signaling to the control of beta cell function and survival","volume":"22","author":"Campbell","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib704","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI106032","article-title":"Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man","volume":"48","author":"Dupre","year":"1969","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib705","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1210\/endo-103-2-610","article-title":"Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas","volume":"103","author":"Pederson","year":"1978","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib706","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1748-1716.1981.tb06731.x","article-title":"Secretory effects of gastric inhibitory polypeptide on the isolated perfused porcine pancreas","volume":"111","author":"Jensen","year":"1981","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.molmet.2025.102118_bib707","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1053\/j.gastro.2009.09.004","article-title":"Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice","volume":"137","author":"Maida","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2025.102118_bib708","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.96.26.14843","article-title":"Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice","volume":"96","author":"Miyawaki","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib709","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diabetes.47.7.1046","article-title":"Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -\/- mice","volume":"47","author":"Pederson","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib710","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcp.2017.02.012","article-title":"GIP(3-30)NH(2) is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release","volume":"131","author":"Sparre-Ulrich","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib711","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1948","article-title":"GIP mediates the incretin effect and glucose tolerance by dual actions on alpha cells and beta cells","volume":"7","author":"El","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.molmet.2025.102118_bib712","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00125-008-1149-y","article-title":"Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas","volume":"51","author":"de Heer","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib713","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0167-0115(91)90035-F","article-title":"Influence of gastric inhibitory polypeptide (GIP) and glucose on the regulation of glucagon secretion by pancreatic alpha cells","volume":"32","author":"Opara","year":"1991","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib714","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1677\/joe.0.1250375","article-title":"Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets","volume":"125","author":"Bailey","year":"1990","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib715","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-2007-1019068","article-title":"Influences of gastro-intestinal polypeptides and glucose on glucagon secretion induced by cholinergic stimulation","volume":"14","author":"Ahren","year":"1982","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.molmet.2025.102118_bib716","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00125-015-3518-7","article-title":"DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice","volume":"58","author":"Malmgren","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib717","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1530\/JOE-15-0463","article-title":"Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice","volume":"229","author":"McShane","year":"2016","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib718","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/BC.2008.019","article-title":"Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets","volume":"389","author":"Cassidy","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib719","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/endo-110-4-1268","article-title":"Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats","volume":"110","author":"Szecowka","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib720","first-page":"G109","article-title":"Gastric glucagon release during gastric and intestinal phase of a meal in dogs","volume":"238","author":"Schusdziarra","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib721","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-003-1103-y","article-title":"Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia","volume":"46","author":"Meier","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib722","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1210\/jc.2013-3644","article-title":"Glucose-dependent insulinotropic polypeptide: blood glucose stabilizing effects in patients with type 2 diabetes","volume":"99","author":"Christensen","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib723","doi-asserted-by":"crossref","first-page":"E1038","DOI":"10.1152\/ajpendo.00665.2010","article-title":"The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes","volume":"300","author":"Lund","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib724","article-title":"Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans","volume":"63","author":"Christensen","year":"2016","journal-title":"Dan Med J"},{"key":"10.1016\/j.molmet.2025.102118_bib725","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jcem-72-1-125","article-title":"Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia","volume":"72","author":"Dupre","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib726","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/dom.12446","article-title":"Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes","volume":"17","author":"Kelly","year":"2015","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib727","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc15-1643","article-title":"Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies","volume":"39","author":"Kazda","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib728","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2337\/db08-0958","article-title":"Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes","volume":"58","author":"Chia","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib729","article-title":"Glucagon lowers glycemia when beta-cells are active","volume":"5","author":"Capozzi","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102118_bib730","article-title":"Intra-islet glucagon signaling is critical for maintaining glucose homeostasis","volume":"5","author":"Zhu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102118_bib731","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2337\/dbi22-0004","article-title":"The liver-alpha-cell Axis in health and in disease","volume":"71","author":"Richter","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib732","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/diab.45.2.257","article-title":"Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells","volume":"45","author":"Moens","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib733","first-page":"327","article-title":"Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients","volume":"81","author":"Willms","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib734","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/diacare.19.6.580","article-title":"Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients","volume":"19","author":"Creutzfeldt","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib735","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2337\/db09-1414","article-title":"The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action","volume":"59","author":"Hare","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib736","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0026-0495(94)90164-3","article-title":"Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man","volume":"43","author":"Hvidberg","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib737","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2015.11.014","article-title":"Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease","volume":"64","author":"Junker","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.molmet.2025.102118_bib738","doi-asserted-by":"crossref","first-page":"R544","DOI":"10.1152\/ajpregu.00123.2015","article-title":"The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1","volume":"309","author":"Plamboeck","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib739","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199205143262003","article-title":"Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus","volume":"326","author":"Gutniak","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib740","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2337\/diab.46.5.792","article-title":"Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism","volume":"46","author":"Ding","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib741","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cels.2016.09.002","article-title":"A\u00a0single-cell transcriptome atlas of the human pancreas","volume":"3","author":"Muraro","year":"2016","journal-title":"Cell Syst"},{"key":"10.1016\/j.molmet.2025.102118_bib742","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","article-title":"Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes","volume":"24","author":"Segerstolpe","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib743","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/modpathol.2014.113","article-title":"Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas","volume":"28","author":"Waser","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.molmet.2025.102118_bib744","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib745","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1152\/physrev.00025.2016","article-title":"The new biology and pharmacology of glucagon","volume":"97","author":"Muller","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.molmet.2025.102118_bib746","first-page":"280","article-title":"Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity\u00a0and insulin from the isolated rat pancreas","volume":"28","author":"Schmid","year":"1990","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.molmet.2025.102118_bib747","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib748","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1104345","article-title":"Type 2 diabetes-a matter of beta-cell life and death?","volume":"307","author":"Rhodes","year":"2005","journal-title":"Science"},{"issue":"Suppl 3","key":"10.1016\/j.molmet.2025.102118_bib749","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib750","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170205","article-title":"Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu(CreERT2);ROSA26-eYFP mice","volume":"125","author":"Sarnobat","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib751","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1515\/BC.2006.118","article-title":"A\u00a0stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones","volume":"387","author":"Marenah","year":"2006","journal-title":"Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib752","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0003-9861(02)00207-2","article-title":"Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling","volume":"403","author":"Arden","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.molmet.2025.102118_bib753","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2025.102118_bib754","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/MCB.22.7.2025-2036.2002","article-title":"Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors","volume":"22","author":"Kops","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib755","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.1068712","article-title":"DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein","volume":"296","author":"Tran","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102118_bib756","doi-asserted-by":"crossref","first-page":"22297","DOI":"10.1074\/jbc.M500540200","volume":"280","author":"Kim","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib757","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/joe.0.1740233","article-title":"Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells","volume":"174","author":"Trumper","year":"2002","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib758","first-page":"1559","article-title":"Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling","volume":"15","author":"Trumper","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib759","doi-asserted-by":"crossref","first-page":"30372","DOI":"10.1074\/jbc.M109.060178","article-title":"Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide","volume":"284","author":"Widenmaier","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib760","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1074\/jbc.M809116200","article-title":"Noncanonical activation of Akt\/protein kinase B in beta-cells by the incretin hormone glucose-dependent insulinotropic polypeptide","volume":"284","author":"Widenmaier","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib761","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2006.10.001","article-title":"GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress","volume":"4","author":"Yusta","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib762","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.52.3.741","article-title":"Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats","volume":"52","author":"Pospisilik","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib763","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1210\/en.2002-0068","article-title":"Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase","volume":"144","author":"Ehses","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib764","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/db08-1651","article-title":"Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice","volume":"58","author":"Tschen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib765","first-page":"E 221","article-title":"Cell cycle control of beta-cell replication in the prenatal and postnatal human pancreas","volume":"300","author":"K\u00f6hler","year":"2011","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib766","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s42255-020-0171-3","article-title":"Targeted pharmacological therapy restores beta-cell function for diabetes remission","volume":"2","author":"Sachs","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib767","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9996","article-title":"GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human beta cell regeneration","volume":"12","author":"Ackeifi","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2025.102118_bib768","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3456","article-title":"Harmine and exendin-4 combination therapy safely expands human beta cell mass in\u00a0vivo in a mouse xenograft system","volume":"16","author":"Rosselot","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2025.102118_bib769","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000414308","article-title":"Metabolic effects of gastric inhibitory polypeptide","volume":"16","author":"Ebert","year":"1987","journal-title":"Front Horm Res"},{"key":"10.1016\/j.molmet.2025.102118_bib770","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0026-0495(76)80002-9","article-title":"Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide","volume":"25","author":"Dupre","year":"1976","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib771","first-page":"183","article-title":"Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue","volume":"125","author":"Knapper","year":"1995","journal-title":"J\u00a0Nutr"},{"issue":"Pt 2","key":"10.1016\/j.molmet.2025.102118_bib772","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj2870337","article-title":"Regulation of the synthesis, processing and translocation of lipoprotein lipase","volume":"287","author":"Braun","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2025.102118_bib773","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)37569-6","article-title":"Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis","volume":"37","author":"Goldberg","year":"1996","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.molmet.2025.102118_bib774","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1194\/jlr.R200015-JLR200","article-title":"Lipoprotein lipase: genetics, lipid uptake, and regulation","volume":"43","author":"Merkel","year":"2002","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.molmet.2025.102118_bib775","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00041433-200210000-00002","article-title":"Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism","volume":"13","author":"Preiss-Landl","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.molmet.2025.102118_bib776","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1172\/JCI110335","article-title":"Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs","volume":"68","author":"Wasada","year":"1981","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib777","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0954-6820.1984.tb03765.x","article-title":"Lack of effect of exogenous or endogenous gastric inhibitory polypeptide on the elimination rate of Intralipid in man","volume":"216","author":"Jorde","year":"1984","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.molmet.2025.102118_bib778","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0167-0115(83)90131-3","article-title":"Effect of endogenous gastric inhibitory polypeptide (GIP) on the removal of triacylglycerol in dogs","volume":"6","author":"Ohneda","year":"1983","journal-title":"Regul Pept"},{"key":"10.1016\/j.molmet.2025.102118_bib779","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.2337\/db10-0098","article-title":"Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans","volume":"59","author":"Asmar","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib780","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/joe.0.1300267","article-title":"Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue","volume":"130","author":"Oben","year":"1991","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib781","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/db17-0480","article-title":"The gluco- and liporegulatory and vasodilatory effects of glucose-dependent insulinotropic polypeptide (GIP) are abolished by an antagonist of the human GIP receptor","volume":"66","author":"Asmar","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib782","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1038\/nutd.2016.15","article-title":"The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss","volume":"6","author":"Asmar","year":"2016","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib783","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.4049\/jimmunol.1401149","article-title":"Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammation","volume":"193","author":"Varol","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.molmet.2025.102118_bib784","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s42255-018-0001-z","article-title":"GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8\/A9","volume":"1","author":"Mantelmacher","year":"2019","journal-title":"Nat Metab"},{"issue":"3","key":"10.1016\/j.molmet.2025.102118_bib785","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174825","article-title":"Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice","volume":"10","author":"Hammoud","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102118_bib786","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0022-3565(25)24585-2","article-title":"Quantitative differences in the cyclic AMP-lipolysis relationships for isoproterenol and forskolin","volume":"244","author":"Allen","year":"1988","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.molmet.2025.102118_bib787","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3565(25)32641-8","article-title":"Relationship among isoproterenol, cyclic AMP, cyclic AMP-dependent protein kinase and lipolysis in perfused fat cells","volume":"218","author":"Sengupta","year":"1981","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.molmet.2025.102118_bib788","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3565(25)32485-7","article-title":"Growth hormone stimulation of lipolysis and cyclic AMP levels in perifused fat cells","volume":"217","author":"Sengupta","year":"1981","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.molmet.2025.102118_bib789","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0167-4889(90)90067-N","article-title":"Hormone-sensitive lipase--a multipurpose enzyme in lipid metabolism","volume":"1052","author":"Yeaman","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2025.102118_bib790","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0021-9258(18)96764-5","article-title":"Effect of insulin on adenosine 3',5'-monophosphate in the rat epididymal fat pad","volume":"241","author":"Butcher","year":"1966","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib791","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1016\/S0021-9258(18)32095-7","article-title":"Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone","volume":"258","author":"Elks","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib792","doi-asserted-by":"crossref","first-page":"15139","DOI":"10.1016\/S0021-9258(18)95713-3","article-title":"cAMP-dependent protein kinase and lipolysis in rat adipocytes. III. Multiple modes of insulin regulation of lipolysis and regulation of insulin responses by adenylate cyclase regulators","volume":"260","author":"Londos","year":"1985","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib793","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1432-1033.1981.tb06191.x","article-title":"The antilipolytic action of insulin on adrenocorticotrophin-stimulated rat adipocytes. The roles of adenosine 3',5'-monophosphate and the protein kinase dependent on adenosine 3',5'-monophosphate","volume":"115","author":"Wong","year":"1981","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.molmet.2025.102118_bib794","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00100.2012","article-title":"Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes","volume":"304","author":"Timper","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib795","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The\u00a0glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib796","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/dom.14545","article-title":"Glucose-dependent insulinotropic polypeptide induces lipolysis during stable basal insulin substitution and hyperglycaemia in men with type 1 diabetes: a randomized, double-blind, placebo-controlled, crossover clinical trial","volume":"24","author":"Heimburger","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib797","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.peptides.2011.02.011","article-title":"Sub-chronic administration of stable GIP analog in mice decreases serum LPL activity and body weight","volume":"32","author":"Szalowska","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib798","article-title":"GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.molmet.2025.102118_bib799","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2024.11.003","article-title":"The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice","volume":"37","author":"Yu","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib800","doi-asserted-by":"crossref","first-page":"E350","DOI":"10.1152\/ajpendo.00008.2008","article-title":"Deficiency of glucose-dependent insulinotropic polypeptide receptor prevents ovariectomy-induced obesity in mice","volume":"295","author":"Isken","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.molmet.2025.102118_bib801","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/jcsm.13346","article-title":"Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia","volume":"14","author":"Takahashi","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.molmet.2025.102118_bib802","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2007.09.128","article-title":"Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes","volume":"364","author":"Yamada","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib803","doi-asserted-by":"crossref","first-page":"E835","DOI":"10.1152\/ajpendo.00646.2020","article-title":"GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism","volume":"320","author":"Boer","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib804","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib805","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI25483","article-title":"Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure","volume":"117","author":"Hansotia","year":"2007","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib806","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molmet.2019.11.018","article-title":"Pharmacological antagonism of the incretin system protects against diet-induced obesity","volume":"32","author":"Svendsen","year":"2020","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib807","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2337\/db16-0758","article-title":"Inhibition of gastric inhibitory polypeptide receptor signaling in adipose tissue reduces insulin resistance and hepatic steatosis in high-fat diet-fed mice","volume":"66","author":"Joo","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib808","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmet.2019.08.006","article-title":"Physiological roles of the GIP receptor in murine brown adipose tissue","volume":"28","author":"Beaudry","year":"2019","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib809","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1210\/clinem\/dgac542","article-title":"GIP affects hepatic fat and Brown adipose tissue thermogenesis but not white adipose tissue transcriptome in type 1 diabetes","volume":"107","author":"Heimburger","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib810","article-title":"Evaluating osteoporosis in chronic kidney disease: both bone quantity and quality matter","volume":"13","author":"Lloret","year":"2024","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.molmet.2025.102118_bib811","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000489672","article-title":"Cortical or trabecular bone: what's the difference?","volume":"47","author":"Ott","year":"2018","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1016\/j.molmet.2025.102118_bib812","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41574-024-01000-z","article-title":"Gut hormones and bone homeostasis: potential therapeutic implications","volume":"20","author":"Bouvard","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib813","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1359\/jbmr.071202","article-title":"Impact of glucose-dependent insulinotropic peptide on age-induced bone loss","volume":"23","author":"Ding","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.molmet.2025.102118_bib814","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvac004","article-title":"GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells","volume":"188","author":"Hansen","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib815","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2015.01.003","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures","volume":"74","author":"Mieczkowska","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib816","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6793-11-12","article-title":"Receptors and effects of gut hormones in three osteoblastic cell lines","volume":"11","author":"Pacheco-Pantoja","year":"2011","journal-title":"BMC Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib817","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1210\/me.2005-0187","article-title":"Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion","volume":"20","author":"Tsukiyama","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib818","doi-asserted-by":"crossref","first-page":"E543","DOI":"10.1152\/ajpendo.00364.2006","article-title":"Effects of glucose-dependent insulinotropic peptide on osteoclast function","volume":"292","author":"Zhong","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib819","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106058","article-title":"GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment","volume":"176","author":"Gabe","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.molmet.2025.102118_bib820","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1210\/jc.2013-3766","article-title":"A\u00a0functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk","volume":"99","author":"Torekov","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib821","doi-asserted-by":"crossref","first-page":"e1608","DOI":"10.1210\/clinem\/dgad734","article-title":"Obesity variants in the GIPR gene are not associated with risk of fracture or bone mineral density","volume":"109","author":"Styrkarsdottir","year":"2024","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib822","doi-asserted-by":"crossref","first-page":"214","DOI":"10.14310\/horm.2002.1405","article-title":"Incretins and bone: evolving concepts in nutrient-dependent regulation of bone turnover","volume":"12","author":"Yavropoulou","year":"2013","journal-title":"Hormones (Basel)"},{"key":"10.1016\/j.molmet.2025.102118_bib823","doi-asserted-by":"crossref","first-page":"E2325","DOI":"10.1210\/jc.2014-2547","article-title":"Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans","volume":"99","author":"Nissen","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib824","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0115426507022003329","article-title":"A\u00a0review of the relationship between parenteral nutrition and metabolic bone disease","volume":"22","author":"Ferrone","year":"2007","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.molmet.2025.102118_bib825","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11894-004-0087-1","article-title":"Metabolic bone disease and parenteral nutrition","volume":"6","author":"Hamilton","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib826","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/jcem.87.7.8660","article-title":"Acute changes of bone turnover and PTH induced by insulin and glucose: euglycemic and hypoglycemic hyperinsulinemic clamp studies","volume":"87","author":"Clowes","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib827","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11914-020-00598-z","article-title":"Update on the acute effects of glucose, insulin, and incretins on bone turnover in\u00a0vivo","volume":"18","author":"Sherk","year":"2020","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib828","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170197","article-title":"GIP and the gut-bone axis - physiological, pathophysiological and potential therapeutic implications","volume":"125","author":"Stensen","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib829","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1210\/jc.2002-021447","article-title":"Octreotide abolishes the acute decrease in bone turnover in response to oral glucose","volume":"88","author":"Clowes","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib830","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1210\/clinem\/dgad431","article-title":"Signs of a glucose- and insulin-independent gut-bone Axis and aberrant bone homeostasis in type 1 diabetes","volume":"109","author":"Hartmann","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib831","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2016.07.014","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption","volume":"91","author":"Mabilleau","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib832","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116065","article-title":"Subcutaneous GIP and GLP-2 inhibit nightly bone resorption\u00a0in postmenopausal women: a preliminary study","volume":"152","author":"Skov-Jeppesen","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib833","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1210\/jc.2017-01949","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) inhibits bone resorption independently of insulin and glycemia","volume":"103","author":"Christensen","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib834","article-title":"Gut Hormones, rather than glucose or insulin, are the main drivers of diminished bone resorption in the postabsorptive state","author":"Lund","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib835","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bone.2007.01.007","article-title":"Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass","volume":"40","author":"Xie","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib836","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/jbmr.4004","article-title":"Enteroendocrine K cells exert complementary effects to control bone quality and mass in mice","volume":"35","author":"Gobron","year":"2020","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.molmet.2025.102118_bib837","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bone.2012.11.039","article-title":"Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice","volume":"53","author":"Gaudin-Audrain","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib838","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bone.2013.07.003","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality","volume":"56","author":"Mieczkowska","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib839","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.4049\/jimmunol.1601441","article-title":"Glucose-dependent insulinotropic polypeptide receptor deficiency leads to impaired bone marrow hematopoiesis","volume":"198","author":"Mantelmacher","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.molmet.2025.102118_bib840","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101008","article-title":"The gut hormone receptor GIPR links energy availability to the control of hematopoiesis","volume":"39","author":"Pujadas","year":"2020","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib841","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/JOE-18-0214","article-title":"Efficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss","volume":"239","author":"Mabilleau","year":"2018","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib842","article-title":"beta-Catenin mediates glucose-dependent insulinotropic polypeptide increases in lysyl oxidase expression in osteoblasts","volume":"14","author":"Daley","year":"2021","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib843","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2014.02.013","article-title":"Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties","volume":"63","author":"Mabilleau","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib844","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/jcp.25033","article-title":"Stable incretin mimetics counter rapid deterioration of bone quality in type 1 diabetes mellitus","volume":"230","author":"Mansur","year":"2015","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib845","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170207","article-title":"GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice","volume":"125","author":"Vyavahare","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib846","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721506","article-title":"[Gly(2)]-GLP-2, but not glucagon or [D-Ala(2)]-GLP-1, controls collagen crosslinking in murine osteoblast cultures","volume":"12","author":"Mieczkowska","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib847","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jbmr.4792","article-title":"Development of a first-in-class unimolecular dual GIP\/GLP-2 analogue, GL-0001, for the treatment of bone fragility","volume":"38","author":"Gobron","year":"2023","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.molmet.2025.102118_bib848","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1253\/circj.CJ-16-0152","article-title":"Suppressive effects of glucose-dependent insulinotropic polypeptide on cardiac hypertrophy and fibrosis in angiotensin II-infused mouse models","volume":"80","author":"Hiromura","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.molmet.2025.102118_bib849","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2017.11.003","article-title":"Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction","volume":"27","author":"Ussher","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib850","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/en.2018-00004","article-title":"GLP-1 receptor expression within the human heart","volume":"159","author":"Baggio","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib851","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.117.028252","article-title":"Multicellular transcriptional analysis of mammalian heart regeneration","volume":"136","author":"Quaife-Ryan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.molmet.2025.102118_bib852","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00520.2014","article-title":"Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics","volume":"308","author":"Karstoft","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib853","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bone.2019.05.014","article-title":"GLP-2 and GIP exert separate effects on bone turnover: a randomized, placebo-controlled, crossover study in healthy young men","volume":"125","author":"Skov-Jeppesen","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib854","article-title":"Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib855","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170174","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease","volume":"125","author":"Heimburger","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib856","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.749607","article-title":"Loss of function glucose-dependent insulinotropic polypeptide receptor variants are associated with alterations in BMI, bone strength and cardiovascular outcomes","volume":"9","author":"Kizilkaya","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib857","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.3615","article-title":"The aging-induced hyperexcretion of glucose-dependent insulinotropic peptide is essential for the healthy cardiac remodeling by prevention of cardiac ceramide accumulation","volume":"41","author":"Kureishi Bando","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.molmet.2025.102118_bib858","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.bbrc.2019.04.036","article-title":"Inhibition of GIP signaling extends lifespan without caloric restriction","volume":"513","author":"Hoizumi","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib859","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2337\/dbi23-0019","article-title":"Redefining diabetic cardiomyopathy: perturbations in substrate metabolism at the heart of its pathology","volume":"73","author":"Heather","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib860","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.118.10845","article-title":"Hypoxia-induced mitogenic factor promotes cardiac hypertrophy via calcium-dependent and hypoxia-inducible factor-1alpha mechanisms","volume":"72","author":"Kumar","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.molmet.2025.102118_bib861","doi-asserted-by":"crossref","DOI":"10.1177\/1479164121999034","article-title":"Glucose-dependent insulinotropic polypeptide inhibits cardiac hypertrophy and fibrosis in diabetic mice via suppression of TGF-beta2","volume":"18","author":"Hiromura","year":"2021","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.molmet.2025.102118_bib862","article-title":"Association of glucose-dependent insulinotropic polypeptide levels with cardiovascular mortality in patients with acute myocardial infarction","volume":"10","author":"Kahles","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.molmet.2025.102118_bib863","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12933-022-01454-3","article-title":"The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury","volume":"21","author":"Kahles","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.molmet.2025.102118_bib864","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00125-020-05093-9","article-title":"Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study","volume":"63","author":"Jujic","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib865","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/eurheartj\/ehz728","article-title":"Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction","volume":"41","author":"Kahles","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.molmet.2025.102118_bib866","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/db15-0122","article-title":"Glucose-dependent insulinotropic polypeptide stimulates osteopontin expression in the vasculature via endothelin-1 and CREB","volume":"65","author":"Berglund","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib867","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/mnfr.200700048","article-title":"Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome","volume":"51","author":"Nitz","year":"2007","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.molmet.2025.102118_bib868","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2350-11-118","article-title":"A\u00a0case-control analysis\u00a0of common variants in GIP with type 2 diabetes and related biochemical parameters in a South Indian population","volume":"11","author":"Sugunan","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.molmet.2025.102118_bib869","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.109.160531","article-title":"Pharmacological characterization of human incretin receptor missense variants","volume":"332","author":"Fortin","year":"2010","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"Suppl 6","key":"10.1016\/j.molmet.2025.102118_bib870","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/bcpt.13289","article-title":"Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system","volume":"126","author":"Gabe","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.molmet.2025.102118_bib871","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/MCB.00256-14","article-title":"A\u00a0naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity","volume":"34","author":"Mohammad","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib872","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101831","article-title":"Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant","volume":"78","author":"Yammine","year":"2023","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib873","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ng.2606","article-title":"Genome-wide meta-analysis identifies 11 new loci for anthropometric traits\u00a0and provides insights into genetic architecture","volume":"45","author":"Berndt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.molmet.2025.102118_bib874","article-title":"Genome-wide physical activity interactions in adiposity - a meta-analysis of 200,452 adults","volume":"13","author":"Graff","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.molmet.2025.102118_bib875","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.2337\/db21-0103","article-title":"Genetically predicted glucose-dependent insulinotropic polypeptide (GIP) levels and cardiovascular disease risk are driven by distinct causal variants in the GIPR region","volume":"70","author":"Bowker","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib876","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ng.521","article-title":"Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge","volume":"42","author":"Saxena","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.molmet.2025.102118_bib877","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00125-021-05564-7","article-title":"Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling","volume":"64","author":"Karhunen","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib878","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EC-17-0015","article-title":"Effects of meal and incretins in the regulation of splanchnic blood flow","volume":"6","author":"Koffert","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.molmet.2025.102118_bib879","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3181\/00379727-158-40222","article-title":"Gastric inhibitory polypeptide increases mesenteric blood flow","volume":"158","author":"Fara","year":"1978","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.molmet.2025.102118_bib880","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/BF01299856","article-title":"Effects of gastric inhibitory polypeptide and glucagon on portal venous and hepatic arterial flow in conscious dogs","volume":"37","author":"Kogire","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib881","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ijo.2013.73","article-title":"Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects","volume":"38","author":"Asmar","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.molmet.2025.102118_bib882","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0196-9781(00)00287-4","article-title":"Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells","volume":"21","author":"Zhong","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib883","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1152\/ajpendo.00509.2002","article-title":"Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1","volume":"285","author":"Ding","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib884","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-0032-1312595","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties","volume":"44","author":"Ojima","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.molmet.2025.102118_bib885","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/en.2018-00336","article-title":"Glucose-dependent insulinotropic polypeptide suppresses peripheral arterial remodeling in male mice","volume":"159","author":"Mori","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib886","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2008.03.006","article-title":"Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis","volume":"199","author":"Ivey","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmet.2025.102118_bib887","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2019.01.007","article-title":"Endothelin-1 levels and cardiovascular events","volume":"30","author":"Jankowich","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.molmet.2025.102118_bib888","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s43856-023-00322-9","article-title":"Endothelin-1 is associated with mortality that can be attenuated with high intensity statin therapy in patients with stable coronary artery disease","volume":"3","author":"Lin","year":"2023","journal-title":"Commun Med"},{"key":"10.1016\/j.molmet.2025.102118_bib889","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1152\/ajpendo.00507.2003","article-title":"Glucose-dependent insulinotropic peptide: differential effects on hepatic artery vs. portal vein endothelial cells","volume":"286","author":"Ding","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib890","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092605","article-title":"Role of nitric oxide in the cardiovascular and renal systems","volume":"19","author":"Ahmad","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib891","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/HYPERTENSIONAHA.114.03837","article-title":"Nitric oxide inhibition of endothelin-1 release in the vasculature: in\u00a0vivo relevance of in\u00a0vitro findings","volume":"64","author":"Rapoport","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.molmet.2025.102118_bib892","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3892\/etm.2017.4279","article-title":"Difference in protective effects of GIP and GLP-1 on endothelial cells according to cyclic adenosine monophosphate response","volume":"13","author":"Lim","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.molmet.2025.102118_bib893","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1006\/bbrc.1993.1327","article-title":"Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries","volume":"191","author":"Winkles","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib894","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)90571-1","article-title":"Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes","volume":"344","author":"Zeiher","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib895","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2000.tb06303.x","article-title":"Role of endothelin-1 in atherosclerosis","volume":"902","author":"Fan","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib896","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0021-9150(92)90263-G","article-title":"Increased plasma concentration of endothelin-1 in cholesterol-fed rats","volume":"93","author":"Miyauchi","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.molmet.2025.102118_bib897","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000164068","article-title":"Diet-induced hypercholesterolemia increases endothelin-1 release by aortic endothelial cells","volume":"64","author":"Uyama","year":"1996","journal-title":"Pathobiology"},{"key":"10.1016\/j.molmet.2025.102118_bib898","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/BF00227448","article-title":"Elevated endothelin levels in patients with hyperlipoproteinemia","volume":"72","author":"Haak","year":"1994","journal-title":"Clin Invest"},{"key":"10.1016\/j.molmet.2025.102118_bib899","first-page":"819","article-title":"Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol","volume":"146","author":"Kowala","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.molmet.2025.102118_bib900","doi-asserted-by":"crossref","first-page":"14367","DOI":"10.1073\/pnas.95.24.14367","article-title":"Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice","volume":"95","author":"Barton","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102118_bib901","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123178","article-title":"The role of osteopontin in atherosclerosis and its clinical manifestations (atherosclerotic cardiovascular diseases)-A narrative review","volume":"11","author":"Kadoglou","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.molmet.2025.102118_bib902","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/dc20-1318","article-title":"Glucose-dependent insulinotropic peptide in the high-normal range is associated with increased carotid intima-media thickness","volume":"44","author":"Jujic","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib903","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12933-023-01940-2","article-title":"GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease","volume":"22","author":"Sachs","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.molmet.2025.102118_bib904","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00125-011-2241-2","article-title":"Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice","volume":"54","author":"Nagashima","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035683","article-title":"Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice","volume":"7","author":"Nogi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib906","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070933","article-title":"Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice","volume":"8","author":"Terasaki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib907","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00047.2009","article-title":"Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives","volume":"91","author":"Chiu","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.molmet.2025.102118_bib908","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101586","article-title":"Genetic disruption of the Gipr in Apoe(-\/-) mice promotes atherosclerosis","volume":"65","author":"Pujadas","year":"2022","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib909","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170233","article-title":"Emerging role of GIP and related gut hormones in fertility and PCOS","volume":"125","author":"Moffett","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib910","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15230","article-title":"The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment","volume":"40","author":"Sridhar","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/j.molmet.2025.102118_bib911","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(24)00538-5","article-title":"Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial","volume":"403","author":"Samarasinghe","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib912","doi-asserted-by":"crossref","first-page":"E2539","DOI":"10.1210\/jc.2014-1180","article-title":"Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome","volume":"99","author":"Chang","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib913","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-0042-101165","article-title":"Basic and meal stimulated plasma GIP levels are higher in lean PCOS women with FAI over 5","volume":"124","author":"Milewicz","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib914","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib915","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cen.12619","article-title":"Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome:\u00a0characteristics and predictive capacity","volume":"83","author":"Cassar","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib916","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.metabol.2008.11.009","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin","volume":"58","author":"Svendsen","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2025.102118_bib917","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ageing\/12.1.54","article-title":"The effect of age and sex on the response of enteropancreatic polypeptides to oral glucose","volume":"12","author":"McConnell","year":"1983","journal-title":"Age Ageing"},{"key":"10.1016\/j.molmet.2025.102118_bib918","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/01.gme.0000172266.47820.43","article-title":"Effect of hormone therapy on the enteroinsular axis","volume":"12","author":"Sztefko","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.molmet.2025.102118_bib919","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2017.11.004","article-title":"Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells","volume":"178","author":"Nishiyama","year":"2018","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib920","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2023.100784","article-title":"Disturbed ovarian morphology, oestrous cycling and fertility of high fat fed rats are linked to alterations of incretin receptor expression","volume":"23","author":"Khan","year":"2023","journal-title":"Reprod Biol"},{"key":"10.1016\/j.molmet.2025.102118_bib921","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/en.2016-1861","article-title":"Food intake affects sperm-egg fusion through the GIP\/PSG17 Axis in mice","volume":"158","author":"Shimizu","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2025.102118_bib922","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0196-9781(85)90086-5","article-title":"The effects of gastric inhibitory polypeptide (GIP) on the release of anterior pituitary hormones","volume":"6","author":"Ottlecz","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib923","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1152\/jn.01161.2007","article-title":"Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid","volume":"99","author":"Gault","year":"2008","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.molmet.2025.102118_bib924","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejphar.2010.10.059","article-title":"Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice","volume":"650","author":"Porter","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib925","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1152\/jn.00866.2010","article-title":"Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis","volume":"105","author":"Faivre","year":"2011","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.molmet.2025.102118_bib926","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157488910791213130","article-title":"Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease","volume":"5","author":"Holscher","year":"2010","journal-title":"Recent Pat CNS Drug Discov"},{"key":"10.1016\/j.molmet.2025.102118_bib927","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2022.955258","article-title":"Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer's and Parkinson's diseases","volume":"14","author":"Holscher","year":"2022","journal-title":"Front Synaptic Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib928","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/revneuro-2015-0021","article-title":"Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease","volume":"27","author":"Ji","year":"2016","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib929","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170184","article-title":"GIP has neuroprotective effects in Alzheimer and Parkinson's disease models","volume":"125","author":"Zhang","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib930","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist-induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib931","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101743","article-title":"GIP receptor agonism blocks chemotherapy-induced nausea and vomiting","volume":"73","author":"Borner","year":"2023","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib932","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/db21-0848","article-title":"GIPR agonism inhibits PYY-induced nausea-like behavior","volume":"71","author":"Samms","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib933","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0031-9384(79)90298-1","article-title":"Effect of cholecystokinin, gastrin, secretin and GIP on sham feeding in the rat","volume":"23","author":"Lorenz","year":"1979","journal-title":"Physiol Behav"},{"key":"10.1016\/j.molmet.2025.102118_bib934","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00254497","article-title":"Peptides and the control of meal size","volume":"20","author":"Woods","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib935","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmet.2018.12.001","article-title":"Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism","volume":"20","author":"Mroz","year":"2019","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib936","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/dom.15001","article-title":"Glucose-dependent insulinotropic polypeptide counteracts diet-induced obesity along with reduced feeding, elevated plasma leptin and activation of leptin-responsive and proopiomelanocortin neurons in the arcuate nucleus","volume":"25","author":"Han","year":"2023","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib937","doi-asserted-by":"crossref","first-page":"941","DOI":"10.33549\/physiolres.932151","article-title":"GIP-dependent expression of hypothalamic genes","volume":"60","author":"Ambati","year":"2011","journal-title":"Physiol Res"},{"key":"10.1016\/j.molmet.2025.102118_bib938","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2017.06.031","article-title":"Central administration of GLP-1 and GIP decreases feeding in mice","volume":"490","author":"NamKoong","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib939","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1172\/JCI126107","article-title":"Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition","volume":"129","author":"Kaneko","year":"2019","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib940","first-page":"128","article-title":"CSF and brain indices of insulin resistance, oxidative stress and neuro-inflammation in early versus late Alzheimer's disease","volume":"3","author":"Lee","year":"2013","journal-title":"J\u00a0Alzheimers Dis Parkinsonism"},{"key":"10.1016\/j.molmet.2025.102118_bib941","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt174","article-title":"Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP\/PS1 mouse model","volume":"5","author":"Faivre","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.molmet.2025.102118_bib942","doi-asserted-by":"crossref","first-page":"661","DOI":"10.17219\/acem\/121007","article-title":"The role of GLP-1\/GIP receptor agonists in Alzheimer's disease","volume":"29","author":"Yu","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.molmet.2025.102118_bib943","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","article-title":"Evolving drug delivery strategies to overcome the blood brain barrier","volume":"22","author":"Hersh","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.molmet.2025.102118_bib944","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib945","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102118_bib946","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114187","article-title":"Brain uptake pharmacokinetics\u00a0of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics","volume":"180","author":"Salameh","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib947","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.peptides.2010.01.003","article-title":"The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid","volume":"31","author":"Rodriguez","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib948","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fnins.2017.00224","article-title":"Development and function of the blood-brain barrier in the context of metabolic control","volume":"11","author":"Haddad-Tovolli","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib949","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","article-title":"Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions","volume":"34","author":"Imbernon","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib950","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101407","article-title":"Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation","volume":"55","author":"Costa","year":"2022","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib951","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110953","article-title":"A\u00a0brainstem circuit for nausea suppression","volume":"39","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib952","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/dbi21-0003","article-title":"Single-cell mapping of GLP-1 and GIP receptor expression in the dorsal vagal complex","volume":"70","author":"Ludwig","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib953","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s42255-022-00606-9","article-title":"Hindbrain circuits in the control of eating behaviour and energy balance","volume":"4","author":"Cheng","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib954","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature12596","article-title":"Genetic identification of a neural circuit that suppresses appetite","volume":"503","author":"Carter","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2025.102118_bib955","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1017\/S0007114521002312","article-title":"Overview of the central amygdala role in feeding behaviour","volume":"127","author":"Izadi","year":"2022","journal-title":"Br J Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib956","series-title":"Neuroendocrine control of body energy homeostasis","author":"Affinati","year":"2000"},{"key":"10.1016\/j.molmet.2025.102118_bib957","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81868","article-title":"Molecular and anatomical characterization of parabrachial neurons and their axonal projections","volume":"11","author":"Pauli","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.molmet.2025.102118_bib958","series-title":"Incretin hormones and pharmacomimetics rapidly inhibit AgRP neuron activity to suppress appetite","author":"McMorrow","year":"2024"},{"key":"10.1016\/j.molmet.2025.102118_bib959","doi-asserted-by":"crossref","first-page":"E614","DOI":"10.1152\/ajpendo.00639.2009","article-title":"On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans","volume":"298","author":"Asmar","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib960","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/dc19-0578","article-title":"No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes","volume":"43","author":"Bergmann","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib961","series-title":"American Diabetes Association \u2013 83rd Annual Scientific Sessions; San Diego, CA, USA; 23 \u2013 26 June 2023","article-title":"A\u00a0long-acting glucose dependent insulinotropic polypeptide receptor agonist shows weight loss without nausea or vomiting","author":"Knop","year":"2023"},{"key":"10.1016\/j.molmet.2025.102118_bib962","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/dom.13025","article-title":"Pharmacodynamics, pharmacokinetics, safety and tolerability of the novel dual glucose-dependent insulinotropic polypeptide\/glucagon-like peptide-1 agonist RG7697 after single subcutaneous administration in healthy subjects","volume":"19","author":"Portron","year":"2017","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib963","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/dom.13024","article-title":"Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose-dependent insulinotropic polypeptide\/glucagon-like peptide-1 agonist RG7697 in people with type 2 diabetes mellitus","volume":"19","author":"Schmitt","year":"2017","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib964","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2017.07.011","article-title":"The sustained effects of a dual GIP\/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes","volume":"26","author":"Frias","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib965","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146353","article-title":"GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice","volume":"131","author":"Samms","year":"2021","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2025.102118_bib966","article-title":"Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss","author":"Wean","year":"2024","journal-title":"Mol Metabol"},{"issue":"6","key":"10.1016\/j.molmet.2025.102118_bib967","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","article-title":"The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets","volume":"5","author":"El","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib968","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114001","article-title":"Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors","volume":"177","author":"Yuliantie","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib969","doi-asserted-by":"crossref","first-page":"28030","DOI":"10.1021\/jacs.3c09078","article-title":"Phosphorylation sites of the gastric inhibitory polypeptide receptor (GIPR) revealed by trapped-ion-mobility spectrometry coupled to time-of-flight mass spectrometry (TIMS-TOF MS)","volume":"145","author":"Brown","year":"2023","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.molmet.2025.102118_bib970","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib971","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(21)01443-4","article-title":"Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial","volume":"398","author":"Ludvik","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib972","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jama.2022.0078","article-title":"Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial","volume":"327","author":"Dahl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.molmet.2025.102118_bib973","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"398","author":"Del Prato","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib974","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jama.2023.20294","article-title":"Tirzepatide vs insulin lispro added to basal insulin in type 2 diabetes: the SURPASS-6 randomized clinical trial","volume":"330","author":"Rosenstock","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.molmet.2025.102118_bib975","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S2213-8587(22)00188-7","article-title":"Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial","volume":"10","author":"Inagaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib976","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2213-8587(22)00187-5","article-title":"Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial","volume":"10","author":"Kadowaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib977","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib978","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib979","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41591-023-02344-1","article-title":"Tirzepatide versus insulin\u00a0glargine as second-line or third-line therapy in type 2 diabetes in the\u00a0Asia-Pacific region: the SURPASS-AP-Combo trial","volume":"29","author":"Gao","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib980","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00125-024-06178-5","article-title":"Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention","volume":"67","author":"Jumpertz von Schwartzenberg","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib981","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/s41591-023-02597-w","article-title":"Tirzepatide after intensive lifestyle intervention in adults with overweight\u00a0or\u00a0obesity: the SURMOUNT-3 phase 3 trial","volume":"29","author":"Wadden","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib982","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with\u00a0obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.molmet.2025.102118_bib983","article-title":"Comparative effectiveness of semaglutide and tirzepatide for weight loss in adults with overweight and obesity in the US: a real-world evidence study","author":"Rodriguez","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.molmet.2025.102118_bib984","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib985","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib986","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13543","article-title":"Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials","volume":"24","author":"Alkhezi","year":"2023","journal-title":"Obes Rev"},{"issue":"4","key":"10.1016\/j.molmet.2025.102118_bib987","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib988","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib989","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48267-2","article-title":"Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity","volume":"13","author":"Quddos","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2025.102118_bib990","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215407","article-title":"Glucagon regulation of energy expenditure","volume":"20","author":"Kleinert","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib991","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00125-023-05947-y","article-title":"100 years of glucagon and 100 more","volume":"66","author":"Wewer Albrechtsen","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib992","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2337\/db12-1116","article-title":"Fibroblast growth factor 21 mediates specific glucagon actions","volume":"62","author":"Habegger","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib993","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmet.2017.02.002","article-title":"Monomeric GLP-1\/GIP\/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice","volume":"6","author":"Jall","year":"2017","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib994","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2016.04.001","article-title":"A\u00a0new stable GIP-Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus","volume":"87","author":"Mansur","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.molmet.2025.102118_bib995","doi-asserted-by":"crossref","DOI":"10.2337\/db18-1106-P","article-title":"Effect of a novel long-acting GLP-1\/GIP\/glucagon triple agonist (HM15211) in a NASH and fibrosis animal model","volume":"67","author":"Choi","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib996","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101533","article-title":"Next generation GLP-1\/GIP\/glucagon triple agonists normalize body weight in obese mice","volume":"63","author":"Knerr","year":"2022","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib997","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmet.2022.07.013","article-title":"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept","volume":"34","author":"Coskun","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib998","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2021.12.005","article-title":"Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1\/GIP\/GCG receptor triagonist","volume":"34","author":"Bossart","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib999","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(22)02033-5","article-title":"LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial","volume":"400","author":"Urva","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib1000","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.molmet.2025.102118_bib1001","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2025.102118_bib1002","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","article-title":"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA","volume":"402","author":"Rosenstock","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.molmet.2025.102118_bib1003","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1111\/dom.15875","article-title":"A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy","volume":"26","author":"Knop","year":"2024","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1004","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/dc19-0449","article-title":"Combined GLP-1, oxyntomodulin, and peptide YY improves body weight and glycemia in obesity and prediabetes\/type 2 diabetes: a randomized, single-blinded, placebo-controlled study","volume":"42","author":"Behary","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib1005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/dom.12079","article-title":"Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice","volume":"15","author":"Irwin","year":"2013","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1006","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113723","article-title":"A\u00a0GIP\/xenin hybrid in combination with exendin-4 improves metabolic status in db\/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice","volume":"171","author":"Craig","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1007","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1463-1326.2011.01401.x","article-title":"Dual modulation of GIP and glucagon action by the low molecular weight compound 4-hydroxybenzoic acid 2-bromobenzylidene hydrazide","volume":"13","author":"Franklin","year":"2011","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2337\/db11-1060","article-title":"Gipr is essential for adrenocortical steroidogenesis; however, corticosterone deficiency does not mediate the favorable metabolic phenotype of Gipr(-\/-) mice","volume":"61","author":"Bates","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2025.102118_bib1009","doi-asserted-by":"crossref","first-page":"44632","DOI":"10.1074\/jbc.M111.311779","article-title":"Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain","volume":"286","author":"Ugleholdt","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib1010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbrc.2005.07.164","article-title":"Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action","volume":"335","author":"Zhou","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib1011","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/osp4.164","article-title":"Gastric inhibitory polypeptide receptor antagonist, SKL-14959, suppressed body weight gain on diet-induced obesity mice","volume":"4","author":"Nakamura","year":"2018","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.molmet.2025.102118_bib1012","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2147\/DMSO.S297353","article-title":"GIP receptor antagonist, SKL-14959 indicated alteration of the lipids metabolism to catabolism by the inhibition of plasma LPL activity, resulting in the suppression of weight gain on diets-induced obesity mice","volume":"14","author":"Nakamura","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.molmet.2025.102118_bib1013","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00125-007-0710-4","article-title":"Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets","volume":"50","author":"Gault","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib1014","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-007-0692-2","article-title":"Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob\/ob mice","volume":"50","author":"Irwin","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib1015","doi-asserted-by":"crossref","first-page":"E1746","DOI":"10.1152\/ajpendo.00460.2007","article-title":"GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet","volume":"293","author":"McClean","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib1016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003163","article-title":"Vaccination against GIP for the treatment of obesity","volume":"3","author":"Fulurija","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib1017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/BC.2009.002","article-title":"Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes","volume":"390","author":"Irwin","year":"2009","journal-title":"Biol Chem"},{"key":"10.1016\/j.molmet.2025.102118_bib1018","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1017\/S0007114511005228","article-title":"Evaluation of the long-term effects of gastric inhibitory polypeptide-ovalbumin conjugates on insulin resistance, metabolic dysfunction, energy balance and cognition in high-fat-fed mice","volume":"108","author":"Irwin","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.molmet.2025.102118_bib1019","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1463-1326.2010.01228.x","article-title":"Active immunization against (Pro(3))GIP improves metabolic status in high-fat-fed mice","volume":"12","author":"Montgomery","year":"2010","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"Speliotes","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.molmet.2025.102118_bib1021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2350-10-19","article-title":"Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups","volume":"10","author":"Vogel","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.molmet.2025.102118_bib1022","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2014.10.025","article-title":"Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice","volume":"401","author":"Pathak","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib1023","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/oby.2008.393","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) stimulates transepithelial glucose transport","volume":"16","author":"Singh","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.molmet.2025.102118_bib1024","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102006","article-title":"AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys","volume":"88","author":"Jensen","year":"2024","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1025","doi-asserted-by":"crossref","first-page":"E931","DOI":"10.1152\/ajpendo.00270.2002","article-title":"Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis","volume":"284","author":"Pamir","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib1026","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2019.170152","article-title":"Islet adaptation in GIP receptor knockout mice","volume":"125","author":"Ahren","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib1027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2007.06.003","article-title":"GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion","volume":"276","author":"Cani","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2025.102118_bib1028","first-page":"bvad114","article-title":"SAT037 glucagon-like peptide-1 receptor knockout mice do not compensate for the lack\u00a0of\u00a0incretin action by increasing glucose-dependent insulinotropic\u00a0polypeptide secretion","volume":"7","author":"Galsgaard","year":"2023","journal-title":"J\u00a0Endocr Soci"},{"key":"10.1016\/j.molmet.2025.102118_bib1029","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat3392","article-title":"Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models","volume":"10","author":"Killion","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2025.102118_bib1030","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1111\/bph.15894","article-title":"Glucose-dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet-fed mice","volume":"179","author":"Boer","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1031","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101638","article-title":"Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems","volume":"66","author":"Yang","year":"2022","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1032","article-title":"GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys","volume":"2","author":"Lu","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.molmet.2025.102118_bib1033","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A\u00a0GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"Veniant","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib1034","doi-asserted-by":"crossref","first-page":"e2710","DOI":"10.1210\/clinem\/dgaa327","article-title":"GIP as a therapeutic target in diabetes and obesity: insight from incretin Co-agonists","volume":"105","author":"Holst","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib1035","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s001250051051","article-title":"Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells","volume":"41","author":"Almind","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2025.102118_bib1036","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106848","article-title":"Genetically proxied impaired GIPR signaling and risk of 6 cancers","volume":"26","author":"Rogers","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.molmet.2025.102118_bib1037","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102094","article-title":"Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation","author":"Davies","year":"2025","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib1039","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(08)61246-5","article-title":"Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial","volume":"373","author":"Garber","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib1040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/dc08-1355","article-title":"Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study","volume":"32","author":"Nauck","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2025.102118_bib1041","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib1042","series-title":"European Association for the Study of Diabetes - 59th Annual Meeting; Hamburg, Germany; 2 \u2013 6 October 2023","article-title":"A\u00a0long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy","author":"Knop","year":"2023"},{"key":"10.1016\/j.molmet.2025.102118_bib1043","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1152\/ajpendo.00330.2023","article-title":"The antiemetic actions of GIP receptor agonism","volume":"326","author":"Borner","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2025.102118_bib1044","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2013.08.047","article-title":"The role of vagal neurocircuits in the regulation of nausea and vomiting","volume":"722","author":"Babic","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1045","first-page":"2955","article-title":"Role of the area postrema in vomiting and related functions","volume":"43","author":"Borison","year":"1984","journal-title":"Fed Proc"},{"key":"10.1016\/j.molmet.2025.102118_bib1046","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/frne.1994.1012","article-title":"The area postrema and vomiting","volume":"15","author":"Miller","year":"1994","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.molmet.2025.102118_bib1047","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.physbeh.2015.10.031","article-title":"Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea","volume":"153","author":"De Jonghe","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.molmet.2025.102118_bib1048","doi-asserted-by":"crossref","first-page":"R902","DOI":"10.1152\/ajpregu.90952.2008","article-title":"Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus)","volume":"296","author":"De Jonghe","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.molmet.2025.102118_bib1049","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autneu.2006.09.005","article-title":"Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness","volume":"132","author":"Horn","year":"2007","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib1050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1523\/JNEUROSCI.14-02-00871.1994","article-title":"Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat","volume":"14","author":"Miller","year":"1994","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib1051","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/3576918","article-title":"Radiation-induced emesis in the dog: effects of lesions and drugs","volume":"108","author":"Carpenter","year":"1986","journal-title":"Radiat Res"},{"key":"10.1016\/j.molmet.2025.102118_bib1052","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(85)90103-X","article-title":"Discrete lesions of the area postrema abolish radiation-induced emesis in the dog","volume":"53","author":"Harding","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.molmet.2025.102118_bib1053","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0022-3565(25)11981-2","article-title":"Emetic action of nicotine and lobeline","volume":"121","author":"Laffan","year":"1957","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.molmet.2025.102118_bib1054","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0196-9781(89)90069-7","article-title":"Identification and characterization of the emetic effects of peptide YY","volume":"10","author":"Harding","year":"1989","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib1055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-8993(98)00584-8","article-title":"Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem","volume":"801","author":"Thiele","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.molmet.2025.102118_bib1056","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/npp.2015.220","article-title":"The aversive agent lithium chloride suppresses phasic dopamine release through central GLP-1 receptors","volume":"41","author":"Fortin","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmet.2025.102118_bib1057","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejphar.2011.11.007","article-title":"Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice","volume":"674","author":"Faivre","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1058","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jnc.13736","article-title":"Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells","volume":"139","author":"Jalewa","year":"2016","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.molmet.2025.102118_bib1059","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.3390\/ijms15045596","article-title":"Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide","volume":"15","author":"Maino","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib1060","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1067020","article-title":"The molecular biology of memory storage: a dialogue between genes and synapses","volume":"294","author":"Kandel","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102118_bib1061","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.conb.2018.08.006","article-title":"Long-term plasticity of hippocampal interneurons during in\u00a0vivo memory processes","volume":"54","author":"Lamsa","year":"2018","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.molmet.2025.102118_bib1062","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.peptides.2006.05.011","article-title":"Effects of glucose-dependent insulinotropic peptide on behavior","volume":"27","author":"Ding","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib1063","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejphar.2011.11.007","article-title":"Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice","volume":"674","author":"Faivre","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1064","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/FBP.0b013e32833c8544","article-title":"Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases","volume":"21","author":"Figueiredo","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1065","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/jnr.22001","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth","volume":"87","author":"Buhren","year":"2009","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.molmet.2025.102118_bib1066","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/neu.2015.3877","article-title":"Temporal and regional expression of glucose-dependent insulinotropic peptide\u00a0and its receptor in spinal cord injured rats","volume":"33","author":"Marcos","year":"2016","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.molmet.2025.102118_bib1067","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-291X(03)01361-5","article-title":"Glucose-dependent insulinotropic polypeptide\u00a0analogues and their therapeutic potential for the treatment\u00a0of\u00a0obesity-diabetes","volume":"308","author":"Gault","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2025.102118_bib1068","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2012.10.045","article-title":"The incretin analogue D-Ala(2)GIP reduces plaque load, astrogliosis and oxidative stress in an APP\/PS1 mouse model of Alzheimer's disease","volume":"228","author":"Duffy","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmet.2025.102118_bib1069","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt174","article-title":"Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP\/PS1 mouse model","volume":"5","author":"Faivre","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.molmet.2025.102118_bib1070","first-page":"267","article-title":"D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model","volume":"35","author":"Faivre","year":"2013","journal-title":"J\u00a0Alzheim Dis : JAD"},{"key":"10.1016\/j.molmet.2025.102118_bib1071","first-page":"695","article-title":"DAla2-GIP-GLU-PAL protects against cognitive deficits and pathology in APP\/PS1 mice by inhibiting neuroinflammation and upregulating cAMP\/PKA\/CREB signaling pathways","volume":"80","author":"Yuan","year":"2021","journal-title":"J\u00a0Alzheim Dis : JAD"},{"key":"10.1016\/j.molmet.2025.102118_bib1072","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.ne.11.030188.000501","article-title":"MPTP toxicity: implications for research in Parkinson's disease","volume":"11","author":"Kopin","year":"1988","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib1073","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2015.10.002","article-title":"Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model","volume":"101","author":"Li","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2025.102118_bib1074","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2016.11.050","article-title":"D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation","volume":"797","author":"Li","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","article-title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","volume":"138","author":"Allen","year":"2013","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.molmet.2025.102118_bib1076","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.molmet.2025.102118_bib1077","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.molmet.2025.102118_bib1078","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2017.03.059","article-title":"Effect of D-Ala2GIP, a stable GIP receptor agonist on MPTP-induced neuronal impairments in mice","volume":"804","author":"Verma","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1079","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041153","article-title":"Glucose-dependent insulinotropic polypeptide mitigates 6-OHDA-induced behavioral impairments in Parkinsonian rats","volume":"19","author":"Yu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molmet.2025.102118_bib1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171271","article-title":"Tirzepatide shows neuroprotective effects via regulating brain glucose metabolism in APP\/PS1 mice","volume":"179","author":"Yang","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.molmet.2025.102118_bib1081","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12967-024-04927-z","article-title":"Tirzepatide prevents neurodegeneration through multiple molecular pathways","volume":"22","author":"Fontanella","year":"2024","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.molmet.2025.102118_bib1082","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of lixisenatide in early Parkinson's disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2025.102118_bib1083","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.molmet.2025.102118_bib1084","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.09.023","article-title":"Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease","volume":"136","author":"Athauda","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2025.102118_bib1085","first-page":"S9","article-title":"Evaluation of liraglutide in the treatment of Alzheimer's disease","volume":"17","author":"Edison","year":"2022","journal-title":"Alzheimer & Dementia"},{"key":"10.1016\/j.molmet.2025.102118_bib1086","doi-asserted-by":"crossref","DOI":"10.1002\/alz.080538","article-title":"MRI changes following treatment of GLP-1 analogue, liraglutide in ALZHEIMER\u2019S disease: ELAD trial","volume":"19","author":"Edison","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.molmet.2025.102118_bib1087","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109952","article-title":"Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: a revolution in the making?","volume":"253","author":"Holscher","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2025.102118_bib1088","series-title":"A\u00a0phase II, randomized, double-blinded, placebo-controlled trial of liraglutide in Parkinson's disease","author":"Hogg","year":"2023"},{"key":"10.1016\/j.molmet.2025.102118_bib1089","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158205","article-title":"Long-term treatment with liraglutide, a Glucagon-Like Peptide-1 (GLP-1) receptor agonist, has No effect on beta-amyloid plaque load in two transgenic APP\/PS1 mouse models of alzheimer's disease","volume":"11","author":"Hansen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2025.102118_bib1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102019","article-title":"The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP\/PS1 mice","volume":"89","author":"Forny Germano","year":"2024","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102118_bib1091","article-title":"Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases","author":"Rhea","year":"2023","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.molmet.2025.102118_bib1092","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuropharm.2018.02.012","article-title":"Two novel dual GLP-1\/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease","volume":"133","author":"Feng","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2025.102118_bib1093","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/WNR.0000000000000548","article-title":"A\u00a0novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain","volume":"37","author":"Cao","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.molmet.2025.102118_bib1094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2015.09.035","article-title":"A\u00a0novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF","volume":"1634","author":"Ji","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.molmet.2025.102118_bib1095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neuropharm.2017.02.013","article-title":"A\u00a0novel GLP-1\/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease","volume":"117","author":"Jalewa","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2025.102118_bib1096","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.molmet.2025.102118_bib1097","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.054","article-title":"Neuroprotective effects of lixisenatide and liraglutide in the MPTP mouse model of Parkinson's disease","volume":"303","author":"Liu","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.molmet.2025.102118_bib1098","first-page":"195","article-title":"The novel DA-CH3 dual incretin restores\u00a0endoplasmic reticulum stress and autophagy impairments to attenuate Alzheimer-like pathology and cognitive decrements in the\u00a0APPSWE\/PS1DeltaE9 mouse model","volume":"66","author":"Panagaki","year":"2018","journal-title":"J\u00a0Alzheim Dis : JAD"},{"key":"10.1016\/j.molmet.2025.102118_bib1099","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2017.06.029","article-title":"A\u00a0novel GLP-1\/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease","volume":"812","author":"Yuan","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.molmet.2025.102118_bib1100","first-page":"523","article-title":"The novel dual GLP-1\/GIP receptor agonist DA-CH5 is superior to single GLP-1 receptor agonists in the MPTP model of Parkinson's disease","volume":"10","author":"Zhang","year":"2020","journal-title":"J\u00a0Parkinson Dis"},{"key":"10.1016\/j.molmet.2025.102118_bib1101","article-title":"DA5-CH and semaglutide protect against neurodegeneration and reduce alpha-synuclein levels in the 6-OHDA Parkinson's disease rat model","volume":"2022","author":"Zhang","year":"2022","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.molmet.2025.102118_bib1102","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4103\/1673-5374.303045","article-title":"Glucagon-like peptide-1\/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model","volume":"16","author":"Zhang","year":"2021","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.molmet.2025.102118_bib1103","doi-asserted-by":"crossref","DOI":"10.1177\/1533317520953041","article-title":"The dual GLP-1\/GIP receptor agonist DA4-JC shows superior protective properties compared to the GLP-1 analogue liraglutide in the APP\/PS1 mouse model of alzheimer's disease","volume":"35","author":"Maskery","year":"2020","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.molmet.2025.102118_bib1104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbr.2017.03.032","article-title":"A\u00a0novel dual GLP-1\/GIP receptor\u00a0agonist\u00a0alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model","volume":"327","author":"Shi","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.molmet.2025.102118_bib1105","first-page":"63","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J\u00a0Alzheim Dis : JAD"},{"key":"10.1016\/j.molmet.2025.102118_bib1106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2018.02.027","article-title":"Glucagon-like peptide-1 mediates effects of oral galactose in streptozotocin-induced rat model of sporadic Alzheimer's disease","volume":"135","author":"Knezovic","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmet.2025.102118_bib1107","first-page":"799","article-title":"A\u00a0GLP-1\/GIP dual receptor agonist DA4-JC effectively attenuates cognitive impairment and pathology in the APP\/PS1\/Tau model of Alzheimer's disease","volume":"83","author":"Cai","year":"2021","journal-title":"J\u00a0Alzheim Dis : JAD"},{"key":"10.1016\/j.molmet.2025.102118_bib1108","article-title":"A\u00a0dual GLP-1\/GIP receptor agonist is more effective than liraglutide in the A53T mouse model of Parkinson's disease","volume":"2023","author":"Zhang","year":"2023","journal-title":"Parkinsons Dis"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:19:29Z","timestamp":1744503569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877825000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":1108,"alternative-id":["S2212877825000250"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102118","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucose-dependent insulinotropic polypeptide (GIP)","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102118"}}